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Three-dimensional cell cultures are indispensible as they mimic the cell-cell and 
cell-matrix interactions in vivo. To date, biomaterials like scaffolds and hydrogels 
have been used for engineering 3D cellular or tissue constructs. However, the 
introduction of such bulk biomaterials might not be suitable for engineering 
constructs of cell-dense and matrix-poor tissues of the internal organs. To engineer 
3D cellular and tissue constructs with minimal biomaterials, we developed an inter-
cellular polymeric linker to facilitate cell-cell interaction and cellular aggregation. 
The cells in the cellular aggregates proliferated, grew compact and maintained 3D 
cell morphology while the inter-cellular linker disappeared from the cell surfaces in 
5 days. Structural characterisation and functional assessment showed that the cellular 
aggregates remodeled during culture to exhibit features of a mature 3D spheroid with 
formation of adherens junctions, secretion of extra-cellular matrix, development of 
gradients of cell proliferation and oxygen concentration from the periphery to the 
centre, good cellular functions and resistance to drug penetration. We further 
incorporated the use of the inter-cellular linker into a 3D microfluidics system to 
take advantage of the micron-scale and fluidic properties for applications, and at the 
same time we created a novel method for seeding and culturing mammalian cells 
three-dimensionally in microfluidic systems without hydrogels. The 3D microfluidic 
cellular constructs exhibited higher cellular functions than 2D-cultured cells and 
demonstrated potential for real-time optical-based monitoring of cellular events with 
good spatial and temporal resolution. The inter-cellular linker hence allows the 
formation of functional 3D cell-dense constructs for tissue engineering applications.   
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Three-dimensional (3D) cell cultures are indispensible as they mimic the cell-cell 
and cell-matrix interactions in tissues in vivo, which are necessary for predicting 
cellular responses of real organisms.1, 2 Classical tissue engineering approaches use 
porous matrices, or scaffolds, for seeding cells,3-5 whereby the cells are essentially 
attached to the two-dimensional (2D) or pseudo-3D surfaces of the scaffolds. To 
culture cells in 3D, hydrogels of various kinds have been employed to encapsulate 
cells.6-8 However, these bulk biomaterials may not be appropriate for engineering 
constructs of cell-dense and matrix-poor tissues of the internal organs, or even 
tumour models.9-11 Another approach to engineer cellular and tissue constructs 
with minimal or reduced use of biomaterials is to mimic the in vivo developmental 
process in which cells are first assembled into cellular structures before the cells 
secrete their own extra-cellular matrix and other environmental cues for structural 
support. In vitro, cells have been grown into cell sheets as the basic building blocks 
which can be stacked up into larger 3D tissue structures for various applications.12 
To precision-engineer complex tissues and organs, 3D basic building blocks 
beyond cell sheets would be essential. Aggregation of one or more cell types 
presents an initial step to construct 3D basic building blocks in vitro.10, 11 
This thesis project aims to engineer 3D cell-dense constructs for in vitro 
studies by using an inter-cellular polymeric linker that facilitates aggregation of 
cells. Being low molecular weight molecules, (Mw ~ 2000 Da) the inter-cellular 
linker allows the formation of cellular constructs with a high ratio of cell to 
biomaterial volume, a feat unattainable when using conventional bulk biomaterials 
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like scaffolds and hydrogels. The cellular aggregates formed with the inter-cellular 
linker were then structurally characterised and functionally assessed for growth 
maturation. Finally, as there is growing interest to miniaturise in vitro models for 
achieving more controllable and reproducible cell culture microenvironment and 
higher throughput experimentation compared to their macro-scale counterparts,13, 
14 we incorporated the use of the inter-cellular linker into a microfluidics system to 
engineer 3D cell-dense micro-constructs for applications. At the same time we 
created a novel method for seeding and culturing mammalian cells three-
dimensionally and at high density in microfluidic systems without using hydrogels.  
To provide a background for these studies, a literature review is presented 
in the next chapter, detailing the importance of 3D culture and the various 
strategies employed to culture cells in 3D. The advantages of micro-scale cell 
culture are also discussed, with emphasis on microfluidic cell culture systems. The 
chapter ends with a review of 3D micro-scale cell culture and limitations of current 
3D cell culture strategies, which lead to the three specific aims of this thesis, 
presented in Chapter 3. Chapter 4 describes the methodologies used in these 
studies. In Chapters 5 and 6, the results and discussion of the three specific aims 
are presented respectively. Chapter 7 concludes the major findings of the studies 
and their implications. The thesis ends with Chapter 8 with recommendations for 





2. BACKGROUND AND SIGNIFICANCE 
This chapter presents background information that defines the rationale for the 
thesis research. Section 2.1 elucidates the biological relevance of three-
dimensional (3D) cell culture as opposed to conventional two-dimensional (2D) 
monolayer cultures, and the various strategies for 3D cell culture. Section 2.2 deals 
with micro-scale cell cultures, a field that integrates microfabrication technology 
from the electronics industry and cell culture for microtissue engineering.  Section 
2.3 reviews various efforts to create 3D micro-scale cell cultures. Section 2.4 
concludes with the limitations of current 3D cell culture strategies, and hence the 
rationale for the thesis research.  
 
2.1 3D cell culture  
2.1.1 Importance of 3D cell culture 
In vivo, cells connect to one another and their surrounding extra-cellular matrix 
(ECM). The ECM acts as a support network that contains proteins such as collagen, 
elastin and laminin, which gives the tissues their mechanical properties and help to 
organise communication between cells embedded in the matrix. Receptors on the 
surface of the cells, e.g. integrins, anchor to the ECM and also determine how the 
cells interpret biochemical cues from the immediate surroundings.1, 15 This complex 
mechanical and biochemical interplay is not reproduced when cells are cultured in 
2D. Two-dimensional cell cultures, conveniently used for the maintenance of cells 
and biological studies, impose highly unnatural geometric and mechanical 
constraints on cells. Conversely, 3D cell cultures re-establish cell-cell and cell-ECM 
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interactions and can mimic real tissues better than conventional 2D cultures.1, 2 For 
instance, a 3D culture environment has been found to promote epithelial polarity and 
differentiation for breast epithelial cells, a phenomenon not observed when the cells 
are cultured in 2D.16 Primary hepatocytes have been found to exhibit higher levels of 
differentiated functions, such as albumin synthesis, when cultured in 3D 
microenvironments, whereas they rapidly de-differentiate and lose their functions 
when cultured in 2D.17, 18 Cancer cells switch from a mesenchymal (spindle-shaped 
cells) to an amoeboid (ellipsoid-shaped cells) motility pattern when cultured in 3D, 
an occurrence never observed in 2D.19  
Gene expression profiles of cells grown in 2D and 3D are also starkly 
different. For example, vascular smooth muscle cells (SMCs) grown in 2D and 3D 
differed for 99 genes. SMCs cultured in 3D showed higher expression of p21, 
correlating to their decreased proliferation rate, while higher expression of matrix 
proteins collagen I and fibrinogen indicated that SMCs were more active in ECM 
production in 3D matrix.20 Microarray analysis of melanoma cells cultured as 3D 
spheroids reported an up-regulation of 106 genes and a down-regulation of 73 genes 
as compared to 2D monolayer. In particular, a number of genes encoding for 
chemokines and pro-angiogenic factors, which are associated with melanoma 
progression and metastasis, were up-regulated in 3D spheroids.21 Generally, cells 
cultured in 3D maintain a gene expression profile that is closer to tissues in vivo,15 




2.1.2 Strategies for 3D cell culture 
To grow cells in 3D, cells have to be supported in a structure that mimics the ECM 
in vivo. Classical 3D tissue engineering approaches use scaffolds like porous 
matrices for seeding cells6 and hydrogels for encapsulating cells.6-8 Another 
approach is via the scaffold-free methods where cells are first assembled into 
cellular structures for the cells to secrete their own ECM and other environmental 
cues to support the structures. In vitro, cells have been grown into cell sheets as the 
basic building blocks that are stacked up into larger 3D tissue structures for various 
applications.12 Aggregation of one or more cell types to form multi-cellular 
aggregates or spheroids where cells are supported by other cells without the use of 
biomaterials is another 3D culture method that has found various applications.10 
The various strategies for 3D cell cultures are described below. 
 
(1) Scaffolds for 3D support 
i) Cell seeding in porous 3D matrices 
Porous 3D matrices, also commonly called scaffolds, have been developed with 
particular applications in tissue engineering. These matrices can have stochastic 
architectures that are fibrous or sponge-like, or organised architectures (Figure 1).  
Matrices with a fibrous structure are typically fabricated using an electrospinning 
process that can continuously generate fibres with diameters in the micro- or nano-
scale.22 Fibrous matrices have a high surface-to-volume ratio and a structure 
similar to the 3D fibre network of collagen and elastin in natural ECM, but their 
small pores hinder cell migration into the scaffold after cell seeding.23 Matrices 
with sponge-like structures are fabricated using freeze-drying and gas-foaming 
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techniques,24 and have porosity and surface-to-volume ratio that is similar to or 
lower than those of fibrous matrices, but their larger pores can significantly 
improve cell seeding and migration.24 Matrices with organised architectures are 
fabricated with fused deposition modelling (FDM), a technique that allows the 
design of various lay-down patterns, pore sizes, and porosity.25 These matrices 
provide good structural integrity and organisational backbone for culturing cells in 
3D, especially in applications where mechanical support is desired, e.g., bone and 
cartilage tissue engineering.3, 26 Hepatocytes cultured in porous matrices formed 
spheroids (compact 3D cell aggregates) and recovered typical morphological 
features in the liver and long term tissue-specific functions such as albumin 
secretion and drug metabolism.27 PLGA scaffolds have also been used for 3D 
tumour-like tissue formation from various types of carcinoma cell with enhanced 
angiogenic capability and reduced sensitivity to chemotherapy.28 Osteogenic and 
chondrogenic cells have been shown to grow, proliferate, distribute, and produce 




Figure 1 (A) Polarised light image of electrospun collagen nanofibres as fibrous 
scaffold.29 (B) SEM image of a tetraethoxysilane (TEOS) - 
polydimethylsiloxane (PDMS) sponge-like scaffold.30 (C) SEM image of 
polycaprolactone (PCL) scaffold structure produced by fused deposition 
modeling (FDM).25 Images are reproduced with permission from publishers. 
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ii) Cell encapsulation in hydrogels 
Hydrogels are hydrophilic polymer networks with high affinity for water but are 
prevented from dissolving due to their chemically or physically cross-linked 
network.31, 32 Water can penetrate the polymer chains and subsequently cause 
swelling and hence the formation of a hydrogel. The high water content of 
hydrogels mimics the natural ECM, making hydrogels suitable for biological 
applications.31 Hydrogels can be derived from natural sources such as collagen, 
hyaluronic acid (HA), fibrin, alginate, agarose and chitin,7 which have low toxicity 
and high biocompatibility. Synthetic hydrogels are also available, including 
poly(hydroxymethyl methacrylate) (PHEMA), poly(ethylene glycol) (PEG) and 
poly(vinyl alcohol) (PVA),31 with PEG being the most commonly used. For 3D 
cell encapsulation, cells are suspended in liquid hydrogels, and gelation is triggered 
using external stimuli such as changes in physical (e.g. temperature) or chemical 
conditions (e.g. ionic strength).33 The hydrogel thus surrounds the cells completely 
in a 3D environment, enabling the delivery of signals to cells from all directions. 
Hydrogels have been used extensively in constructing 3D in vitro cell culture 
systems in which cellular morphogenesis, function, migration, and differentiation 
are distinctly different from conventional 2D culture. For example, breast epithelial 
cells cultured within 3D hydrogel formed an acinus structure possessing a cellular 
morphology akin to that of an in vivo structure that was never observed in 2D 
culture.34 Migration studies have shown that fibroblasts on a 2D substrate have a 
different shape and a different distribution of transmembrane adhesion proteins 
compared with fibroblasts within 3D collagen gels.35 
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Hydrogels have also been used as the medium for assembling living cells 
into 3D structures, where cells are deposited and allowed to fuse spontaneously, in 
a method termed “organ printing”.36 Printing of cell aggregates and embryonic 
heart mesenchymal fragments resulted in fusion of the cells into a tube-like 
structure when placed in a 3D collagen or thermosensitive gel (Figure 2).37 If 
successful, this type of technology could allow for cells to be placed into precise 
locations within a 3D tissue construct. 
 
 
Figure 2 (A) Schematic representation of principle of organ printing technology: 
placing of cell aggregates layer by layer in solidifying thermo-reversible gel 
with sequential cell aggregate fusion and morphing into 3D tube. (B) Ten 
aggregates (containing ~ 5000 cells) before fusion. (C) Final disc-like 





(2) Scaffold-free strategies 
Although scaffolds like porous matrices and hydrogels offer unique clinical 
opportunities in tissue engineering strategies that require a strict structural support, 
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shape-supporting matrices could be less-suited for the engineering of cell-dense 
and ECM-poor tissues of the internal organs, e.g. liver, pancreas, or even tumour 
models.10, 38 Therefore engineering tissue constructs with minimal biomaterials and 
even as scaffold-free cellular constructs would be important to recapitulate the 
complex structure-functional relationship in these tissues. Three scaffold-free 
strategies, namely the assembly of cell sheets, spheroid culture and induced 
cellular aggregation, for 3D cell culture are described below. 
 
i) Assembly of cell sheets 
Three-dimensional tissue structures have been engineered by the layer-by-layer 
assembly of cell sheets.12 Confluent cell layers cultured on temperature responsive 
culture surfaces (dishes grafted with poly(N-iso-propylacrylamide) (PNiPAAm)) 
were released as cell sheets by lowering the temperature to hydrate the grafted 
polymer. Various tissues and organs have been constructed with cell sheets using 
different methods. In the cases of skin,39 corneal epithelium,40 urothelium,41 and 
periodontal ligament,42 single cell sheets can be transplanted directly to host tissues 
using two-dimensional manipulation. Multiple sheets of cells can also be layered to 
create an in vitro tissue construct. With homotypic layering of cell sheets, 3D 
structures such as cardiac muscle can be created.43, 44 Finally, using heterotypic 
stratification, laminar structures such as kidney glomeruli and liver lobules45 can 
be constructed (Figure 3).12 Cell sheet engineering can therefore avoid 
conventional tissue engineering approaches using scaffold-based technologies and 
isolated cell injections. However, cellular assembly by manipulating layers of cells 




Figure 3 Tissue reconstruction by assembly of cell sheets. (A) By transplanting single 
cell sheets directly to host tissues, skin, cornea, periodontal ligament, and 
bladder can be reconstructed. (B) Using homotypic layering of cell sheets, 3D 
myocardial tissues can be created. (C) With heterotypic stratification of cell 
sheets, laminar structures such as those in the liver or kidney can be 
fabricated.12 Figure is reproduced with permission from publisher. 
 
ii) Spheroid culture 
Spheroids are aggregates of cells with compact structures. They contain extensive 
ECM and possess a complex 3D network of cell-cell and cell-matrix 
interactions.47-50 Spheroid cultures are more commonly used as tumour models, 
although spheroid cultures of primary cells also exist. Spheroids are formed using 
methods that prevent the attachment of cells onto an external substratum, thereby 
encouraging the cells to aggregate for support in an attempt to prevent anoikis, 
which is apoptosis in response to lack of adhesion or inappropriate adhesion.51, 52 
Various methods for spheroid cultures are described below. 
 
a) Liquid overlay 
Spheroids can be obtained by seeding cells onto a non-adherent surface, e.g. 
bacteriological or agar-coated petri-dishes. Cells do not attach but grow on the 
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surface in a biphasic process: first the cells migrate towards one another and 
aggregate, after which cell growth occurs and results in spheroid formation and 
growth. However, in this method, cell-cell adhesion behaviour can be altered due 
to contact with the substratum.53 This method has been used to produce spheroids 
for cancer studies,54 as well as primary hepatocytes spheroids for liver research.55 
 
b) Hanging drop method  
Originally pioneered for the production of embryoid bodies and blastocysts to 
study the differentiation potential of stem cells,10 spheroid formation using the 
hanging drop method was found to be compatible with a variety of cell types to 
create scaffold-free 3D cultures.56, 57 Single-cell suspensions were dispensed as ~ 
20 micro-litre drops onto a tray; upon inversion of the tray, hanging drops were 
held in place by surface tension (Figure 4), and cells accumulate at the bottom of 
the drop to form tightly-packed spheroids after about 5 days.56 This method is good 
for forming spheroids of uniform sizes, but is only useful for short-term culturing, 
i.e. initiation of spheroid formation, for as long as spheroids are not fed and/or 
treated.47 This method has been used to generate spheroids as a model for the study 




Figure 4 A photograph of hanging-drops. Drops of cell suspensions were dispensed 
onto a tray and the tray inverted.  
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c) Rotational culture methods  
Various rotational culture methods exist to produce spheroids on a larger scale, 
including the roller-tube, spinner flask and gyratory shaker methods (Figure 5). 
The constant rotation prevents the adherence of cells onto any substrate, hence 
encouraging cells to aggregate spontaneously to form spheroids.47, 53 However, the 
rotation may introduce shear forces which may alter cellular behaviour.59, 60 These 
methods are commonly used for producing tumour spheroids for cancer research.47 
 
       
 
 
Figure 5 Rotational culture methods to culture or form spheroids from single cell 
suspensions, adapted.47 (A) Roller-tube method. (B) Spinner flask method. 
(C) Gyratory shaker method. 
 
iii) Induced cellular aggregation 
Relying on the cells’ natural ability to aggregate and form spheroids using the above 
methods require a long cultivation time, ranging from a few days to weeks. Hence 
surface modification of cells has emerged as a means to accelerate cell aggregation. 
Engineering 3D cellular aggregates can be conceptually accomplished by  modifying 
cell surfaces to generate reactive handles and gluing cells by a multi-arm inter-
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cellular molecular linker reacting with the reactive handles on cell surfaces. Cell 
surfaces can be modified genetically, via enzymatic treatment, or chemically to 
generate reactive handles.61 Rat cerebral cell lines have been transfected with neural 
cell-adhesion molecules (N-CAM) to encourage cellular aggregation.62 ManLev, a 
metabolic substrate, taken up by cells can be metabolically incorporated into 
modified cell-surface glycoproteins as reactive handles for ligation with probes.63-65 
Galactose oxidase have been used to oxidise the terminal galactosyl residues of cell-
surface glycoproteins to generate ketone handles for ligation with reactive 
biomolecules.66 Cell surfaces can also be chemically “painted” with exogenously-
added glycoinositol phospholipid (GPI)-anchored proteins of interest for studying 
cell-cell interactions.67 Chemical modification of sialic acids on cell-surface 
glycoproteins with sodium periodate has also been carried out to generate aldehyde 
handles on cell surfaces, which enable the cell surfaces to be decorated with reactive 
hydrazide species. These decorated cells are then aggregated with a further step 




Figure 6 The induction of cell aggregation by cell surface engineering. Schematic 
representation of the aggregation concept, where biotinylated cells in 
suspension are cross-linked by addition of avidin.66 Image is reproduced with 
permission from publisher. 
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2.2 Micro-scale cell culture 
2.2.1 Advantages of micro-scale cell culture  
Tissue function is modulated by the spatial organisation of cells on a sub-
millimetre, or micron scale. Hence artificial replication of cellular structures on the 
micron scale is essential for understanding, measuring and simulating their in vivo 
functions in the laboratory.70 Micro-scale technologies such as microfabrication 
techniques offer the ability to engineer tissues on the micro scale,71 better control 
the cellular microenvironment in culture72 and miniaturise cell culture platforms 
for applications.9 With microfabrication techniques, features can be controlled at 
length scales from 1mm to 1 cm; with better control of the cellular 
microenvironment, the biological cell-to-cell and culture-to-culture variability can 
be reduced;72, 73 and with miniaturisation of the cell culture platform, savings in 
terms of the number of cells, samples and reagents required for cell-based assays 
can be generated.74 Furthermore, many identical copies of a single microfabricated 
device can be made cheaply.75, 76 In this section, emphasis is placed on 
microfluidic systems for cell culture, which forms a part of the thesis work, as 
opposed to other microfabricated systems for cell culture.  
 
2.2.2 Microtechnology for engineering micro-scale cell culture systems 
Microfabrication technology originated from the electronics and semiconductor 
industries, where micro-features for electronic devices were manufactured in the 
sub-centimetre to sub-micrometre range. Because these micro-features match the 
size of cells and capillaries, hence mimicking tissue architecture in vivo, 
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microfabrication technology has been applied to tissue engineering.9, 77, 78 This 
newfound capability to exert spatial control on the cells at the micrometre scale has 
allowed the application of microfabrication technology to study fundamental biology 
in a way formerly unattainable by standard tissue culture methods.  For instance, 
cells were seeded into microstructures of various dimensions and shapes to study the 
effects of cell shape on cell growth, migration and differentiation (Figure 7A, B).79, 80  
Cells were also co-cultured with other cell types in spatially-defined adjacent micro-
regions to study the effects of cell-cell interaction and exchange of soluble factors 
between cell types (Figure 7C).81 
 
 
Figure 7 Capability of microtechnology to exert spatial resolution for cell 
culture.Brightfield images of single hMSC plated onto micro-patterned small 
(left column) or large (right column) fibronectin islands.79 Scale bar = 50mm 
Bright-field images of hepatocytes (darker cells) and 3T3 fibroblasts co-
cultured on micro-regions with high spatial resolution.81 Images are 
reproduced with permission from publishers. 
 
2.2.3 Microfluidics as an attractive micro-scale cell culture system 
Microfluidics deals with the behaviour, control and manipulation of fluids in 
channels in the micrometer range, typically 10-100 μm82 and has attracted interest 
from fields such as engineering, physics, chemistry and biotechnology.  Flows in 
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microfluidics exhibit laminar behaviour, hence the flows can only mix by diffusion 
or by active mixing, as there is no chaotic mixing.  This characteristic offers a good 
control over the concentration of molecules in space and time,82, 83 making them 
excellent perfusion cell-culture devices which are powerful tools to control the 
soluble and mechanical factors of the cell culture microenvironment (details 
below).84, 85 Fluid flow in microfluidic devices also mimics vasculature in vivo,86 
hence fluidic introduction of drugs more closely approximates the dose dynamics 
experienced in vivo, compared to static incubation of cells with a bolus dose of 
drugs.75 In addition, the incorporation of fluid flow for cell culture allows efficient 
exchange of nutrients and metabolites between the cells and culture medium, hence 
maintaining a constant cell culture microenvironment.87, 88 
 
(1) Microenvironmental control in microfluidics  
The microfluidic cell culture environment consists of: (i) soluble factors, including 
localised soluble stimuli and their gradients like glucose and oxygen availability;89, 90 
and (ii) mechanical factors, in particular fluid shear stress.91   
 
i) Soluble factors  
Cells constantly interact with soluble bioactive factors like oxygen and glucose in 
their extra-cellular environment to maintain their viability and functions. Secreted 
bioactive factors in the soluble microenvironment, such as cytokines and growth 
factors, must be properly regulated as they are involved in both autocrine and 
paracrine signalling processes, which control vital cell functions, such as 
differentiation, proliferation, and apoptosis.92, 93 Sufficient oxygen and glucose must 
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be supplied to ensure cell survival. Oxygen, in particular, is readily depleted due to 
its relatively low solubility and diffusivity in culture medium. Hence, oxygen 
concentration gradient is significant in cell culture constructs larger than 100-200 
μm.94, 95 Oxygen availability in culture can significantly affect cell fate. For instance, 
reduced oxygen concentrations enhance neuronal differentiation of mouse neural 
cells96 and promote chondrogenesis in rat mesenchymal stem cells.97 Glucose, 
another soluble factor, has significant effects on cell response.  The development of 
embryos is inhibited by high glucose concentrations, although the underlining cause 
is still not known.98 A high glucose level has also been found to induce adipocyte 
differentiation of stem cells from adipose tissue and adipogenic conversion of 
muscle-derived stem cells.99   
However, efforts to define the soluble composition of culture medium in 
conventional static cell culture dishes have been difficult due to the large liquid 
volumes, the constant depletion of growth factors and the accumulation of metabolic 
waste. To conduct studies on the effect of the soluble environment on cell behaviour, 
a homogenous microenvironment that remains spatially and temporally constant is 
crucial. Conventional bulk cell-based assays and techniques can be prohibitive in 
terms of materials, space and time for such extensive studies.77 Microfluidic devices, 
on the other hand, allow the unique ability to control the soluble environment of the 
microenvironment. Static culture environments constantly accumulate metabolic 
waste while depleting glucose and oxygen from the medium, but a non-circulatory 
fluidic perfusion system can ensure constant removal of the waste and replenishment 
of oxygen and glucose, enabling a high degree of control over the soluble factors.100  
Furthermore, high-throughput screening of these factors can be performed with 
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microfluidic gradient generators, allowing different growth conditions to be probed 
in parallel or, in combinatorial fashion101 not achievable in conventional culture 
dishes. The laminar flow characteristic in microfluidics make possible the 
microfluidic gradient generator, which generates a range of concentrations of soluble 
species by sequential merging, mixing and splitting of 2 or more inlet streams, each 
of which contain a particular environmental stimulus.9 Such stable gradients have 
been used to study cell chemotaxis in response to chemo-attractants, yielding 
insights into neutrophils migration in response to various concentrations of IL-8.102 
A review on the generation of soluble gradients using microfluidic technologies has 
been described.103 Thus, microfluidic systems have great potential as tools for 
controlling or investigating the soluble microenvironment for cell cultures. 
 
ii) Mechanical factors 
Mechanical forces present in cell cultures can affect cell behaviour. In microfluidic 
systems, fluid flow exerts fluid shear stress (FSS) on the cells, and is represented by 




mt -=  (1) 
where τ is the shear stress, μ is the fluid viscosity, ν is the fluid velocity, and  x is 
the position in the microfluidic channel.  
FSS has been shown to modulate the phenotypes and functions of various 
cell types. For example, FSS induces a re-organisation of the cytoskeleton in 
endothelial cells such that they are aligned in the direction of the shear vector.105 
Epithelial cells in the kidney and liver are also modulated by FSS. For instance, 
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FSS above 5 dynes cm-2 can result in a decrease of differentiated functions such as 
albumin production and cytochrome P450 enzymatic activities in primary rat 
hepatocytes.106 Murine embryonic kidney epithelial cells respond to an increase in 
FSS across their apical surface by rapidly increasing Ca2+ influx via stress sensitive 
ion channels.107 FSS is also being implicated in the extravasation of tumour cells as 
tumour-endothelial cell interactions is shear dependent.108 
FSS in microfluidic systems is primarily controlled by chamber geometries 
and flow rates, which can be designed such that applied shear stresses can match 
the low magnitudes observed in interstitial flow109 or higher levels in vascular 
flow.110 Methods for mitigating shear stress include lowering fluid velocities;87, 111 
designing chamber geometries to reduce shear stress;109 and including 
microstructures e.g., micro-grooves to shield cell cultures from fluid flow.112 For 
culture in 2D parallel-plate or thin rectangular channels, a parabolic flow profile 







t =  (2) 
 
where τ is the shear stress, μ is the fluid viscosity, Q is the flow rate, h is the 
channel height, and w is the channel width.  
Thus, for a given flow rate Q, the shear stress may be reduced to acceptable 
levels by increasing the channel height (lowering the fluid velocity). The parallel-
plate shear stress estimate is useful when dealing with simple rectangular culture 
channels, but in devices with more complicated geometries, finite-element 
simulations may be used to estimate the FSS profile.109 In the aforementioned 
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methods, cells are assumed to experience FSS equivalent to the wall shear stress. 
Analytical solutions of FSS experienced by single or multiple cells in microfluidic 
channels have been reviewed by Walker et al.104 
Controlled application of shear in spatial and temporal conditions in 
microfluidic devices can be achieved by controlling the flow rate over the cells.  
Similar to gradient concentration generators, it is possible to generate varying flow 
rates on a microfluidic platform.  This enables simultaneous screening of a range 
of shear stress on cell response.87, 113 For instance, murine embryonic stem cells 
experiencing different flow rates are found to form colonies of different sizes.87 
 
iii) Applications 
Microfluidic systems are also amenable to multiplexing for high throughput 
analyses100, 114 and integrating with microfluidic components, such as concentration 
gradient generators100, 115 and computer-controlled on-chip valves, pumps and 
analytical systems74, 82, 116 (Figure 8) resulting in programmable and re-
configurable microfluidic devices.117, 118 Transparent microfluidic platforms are 
also compatible with optical-based in situ assays that utilise fluorescence reporters 
and high resolution imaging modalities, such as confocal microscopy, to probe 
cellular events or monitor cellular responses.115, 119 Hence, microfluidic cell culture 
systems have found applications in many areas of mammalian cell-based research, 
such as cell migration studies,120 gene expression analysis,114 cellular function and 
differentiation studies,121 drug metabolism and toxicity testing,122, 123 disease 




Figure 8 An overview of the possible uses for a multiplexed microfluidic cell culture 
system.  Inputs can be used for control of the stem cell microenvironment and 
drug testing.  The gradient generator creates a concentration profile of the 
input factors. The cell culture chamber is a perfusion system in which the 
cells are seeded.  Analysis involves monitoring the output of the device, 
which can be imaged with the aid of biomarkers, analysed using inline 
sensors or standard lab equipment. 
 
Microfluidic cell culture systems have also been designed to specifically 
mimic certain aspects of the in vivo microenvironment. For instance, human 
microvascular endothelial cells (hMECs) were cultured in a branching microfluidic 
network that was designed to recreate a micro-vascular network that can 
potentially supply nutrients and oxygen to engineered tissue constructs (Figure 
9).127 Microfluidic cell culture systems have been used to emulate the highly 
vascularised cellular microenvironment of the liver so as to maintain the 
differentiated functions of hepatocytes.128 Shuler et al., have designed a series of 
microfluidic cell culture systems to replicate the systemic circulation of blood 
through different organs in an animal.129 The system, known as the cell culture 
analogue, consists of a number of serially connected chambers, culturing cells from 
representative organs e.g., liver, lungs, and fat tissue. This “animal-on-a-chip” 
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concept is envisioned to be further developed into an in vitro physiologically-based 




Figure 9 Human microvascular endothelial (HMEC-1) cells immediately after seeding 
in the networks. Staining of CD31 (an endothelial-specific marker) in a 
branching microfluidic network to recreate a micro-vascular network.127 
Images are reproduced with permission from publisher. 
 
2.3 3D micro-scale cell culture 
To improve the biological relevance of cell culture systems, there is emphasis to 
move from 2D cell culture (where cells are cultured as a monolayer on a flat 
substrate) to 3D cell culture (where cells are supported in all directions by either 
neighbouring cells or extra-cellular  matrix (ECM)).131, 132 Micro-technology was 
thus adapted to create 3D micro-features for cell culture, which mainly consist of 
3D micro-wells for cell entrapment for static culture condition, or 3D microfluidic 




2.3.1 3D micro-well cell culture systems 
The most established 3D micro-scale culture systems uses micro-wells into which 
cells are seeded; the space confinement encourages cells to aggregate and form 
spheroids upon culture.60 Embryonic bodies have been successfully formed within 
microfabricated PEG wells with good viability up to 10 days (Figure 10).133 
Primary rat hepatocytes when seeded in polystyrene and chitosan micro-wells 
formed spheroids and maintained liver-specific functions for more than one 
week.134, 135 Cell lines like HepG2 and MCF-10 have also been cultured in micro-
wells arrays to enable 3D cell based assays in a potentially high throughput 
fashion.136, 137 
 
   
Figure 10 A high density cell suspension was placed on the microwell arrays and 
allowed to settle within the wells.133 Figure is reproduced with permission 
from publisher. 
 
2.3.2 3D microfluidic cell culture systems 
There have not been many 3D microfluidic cell culture systems developed to date, 
possibly because of the operational complexity due to their closed nature, and the 
presence of fluid flow, which contributes to the susceptibility of failure as a result 
of air bubble formation.138 To culture cells three-dimensionally in microfluidic 
systems, the cells must be mechanically supported to withstand fluid perfusion. A 
common strategy is to encapsulate cells three-dimensionally in hydrogels.132, 139 
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Cells are first suspended in liquid hydrogels, flowed into the microfluidic system 
and then encapsulated three dimensionally when gelation sets in. The challenge in 
using hydrogels is the confinement of cell-encapsulating hydrogels in the 
microfluidic network, such that fluid flow is not impeded. Methods like micro-
patterning131, 140 and  hydrodynamic focusing141-143 were employed for localisation 
of the hydrogels within the microfluidic channel in order to allow fluid perfusion. 
In other cases, the space created by the contraction of the cell-laden hydrogel upon 
its gelation allows for culture media perfusion.144 One shortcoming of 
encapsulation of cells in hydrogels for 3D extra-cellular support is that the cells are 
sparsely located and lack cell-cell interactions (Figure 11), making this method 





Figure 11 Encapsulation of cells in hydrogels in microfluidics using various strategies. 
(A) Schematic of the micro-patterning of agarose microfluidic devices with 
(right) and without (left) encapsulated cells to allow fluid perfusion in the 
centre (white region).131 (B) and (C): Low cell density of cellular constructs 
obtained using hydrodynamic focussing of cell-laden PuraMatrix hydrogel141 
(B) and PEG hydrogel143 (C) in the centre to allow fluid perfusion on the 
sides. Figures are reproduced with permission from publishers. 
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2.4 Limitations of current 3D cell culture strategies  
Although a variety of strategies exist for 3D cell culture, there is no single strategy 
that allows the engineering of cell-dense constructs, while having the potential for 
creating complex 3D architecture, and can be used in micro-scale cell culture 
systems simultaneously. The development of a biomaterial that aids the formation 
of 3D cell-dense constructs without spatial restriction and is also sufficiently 
versatile for use in micro-scale cell culture systems would be beneficial for tissue 
engineering and drug testing applications. This forms the basis for the thesis 
research, which is further elaborated in the 3 specific aims in the next chapter. 
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3. OBJECTIVES AND SPECIFIC AIMS 
The concept of culturing cells in 3D as cellular aggregates without scaffold support 
originates from the in vivo developmental process in which cells are first 
assembled into cellular structures before they secrete extra-cellular matrix for 
support.145 In order to engineer a functional, three-dimensional, cell-dense tissue 
construct, we attempt to mimic this process by connecting cells directly but 
transiently with inter-cellular linker to facilitate cell-cell interaction and 
aggregation. The 3D cellular aggregates are then cultured for re-modelling into a 
mature 3D construct. To engineer reproducible 3D cell-dense constructs and 
miniaturise the cell culture platform for applications, we incorporated the use of 
the inter-cellular linker into a microfluidics system. These efforts are elaborated in 
the following sections which outline the 3 specific aims of the thesis research, with 
a hypothesis and rationale for each aim. 
 
 
3.1 Specific Aim 1: To evaluate the inter-cellular polymeric linker for 
engineering a 3D cell-dense culture model  
 
Hypothesis 
Anchorage-dependent cells can be three dimensionally supported by neighbouring 
cells by forming cellular aggregates using inter-cellular polymeric linker, 




While the use of porous matrices or hydrogels as 3D scaffolds is suitable for 
engineering ECM-rich tissues like the bone and cartilage, they are unsuitable for 
engineering constructs of cell-dense and matrix-poor tissues of the internal organs.9 
Scaffold-free strategies like the assembly of cell sheets or spheroid culture are 
highly suited for engineering cell-dense tissues due to the absence of exogenous 
biomaterials as scaffolds, but cellular assembly by manipulating layers of cells is 
limited in the complexity of architectures that can be formed;46 and spheroid 
culture relies on the cells’ ability to establish cell-cell contact, a process which may 
take from days to weeks,146 or never at all for certain cell types147 and does not 
allow control over the structure formed. Hence a method that  
1) uses minimal biomaterials to create a cell-dense model,  
2) allows formation of complex 3D tissue architecture not confined to sheets, and  
3) does not rely on the cells’ natural ability to establish cell-cell contacts  
would be helpful for engineering 3D cell-dense tissues. 
Here we aim to fulfil these 3 criteria by developing an inter-cellular 
polymeric linker that facilitates cell–cell interaction and aggregation. The inter-
cellular polymeric linker is based on non-toxic low molecular-weight 
polyethyleneimine (PEI)148 which contains multiple amine arms on a positively-
charged backbone. The primary amine groups on PEI arms were modified to yield 
hydrazides which can react with the aldehyde handles on chemically modified cell 
surfaces to form 3D cellular aggregates within 30 minutes. The inter-cellular linker 
possesses the following features: 
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1) Being a polymer of low molecular weight (Mw ~ 2000 Da), the inter-cellular 
linker uses minimal scaffold to provide support for cells compared to porous 
matrices or hydrogels. 
2) The inter-cellular linker aggregates cells in liquid suspension in 3D to form 
cellular aggregates without dimensional confinement. This potentially allows 
controlled manipulation of cells for complex 3D tissue architectural construction 
with the aid of other technologies, e.g. dielectrophoretic patterning or stenciling 
methods. 
3) The inter-cellular linker reacts with the aldehyde handles that are generated on 
cell surfaces by chemically modifying cell-surface glycoproteins (sialic acids) with 
sodium periodate.68 Hence the process does not rely on the cells’ natural ability to 
establish cell-cell contacts. This enables rapid aggregation of cells in 30 minutes.  
 
A similar cell aggregation system that makes use of avidin-biotin-hydrazide 
inter-cellular linker on chemically-modified cells for cell aggregation exists,68 and 
has shown that anchorage-dependent cells can be three dimensionally supported by 
neighbouring cells by forming cellular aggregates. However, the process of 
biotinylating the cells and cross-linking them with avidin requires multiple steps 
and takes a longer time. Here we improved on the concept by including a 
polymeric inter-cellular linker that combined the multiple steps into one. 
Simplifying the aggregation process would be useful for future tissue engineering 




· Design, synthesis and characterisation of the inter-cellular linker. 
· Optimisation of the cell aggregation process for maximal cell viability by 
controlling the extent of cell surface modification, and the concentration, 
incubation time and incubation temperature of the inter-cellular linker. 
· Monitoring the cellular aggregates formed with the inter-cellular linker for 
viability, proliferation, morphological changes and maintenance of the 3D 
cell morphology. 
· Tracking the inter-cellular linker on cell surfaces by means of conjugating 




3.2 Specific Aim 2: To assess linker-engineered aggregates for features of a 
mature 3D culture 
 
Hypothesis 
Cellular aggregates engineered using the inter-cellular linker will re-model during 
culture into spheroids with features similar to mature spheroids formed naturally 
using rotational culture methods. 
 
Rationale 
The use of the inter-cellular linker for the formation of 3D cultures is only useful if 
the engineering process accelerates the formation of a mature 3D culture from 
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single cells without altering the cellular behaviour. Here, mature spheroids formed 
naturally using rotational culture methods are used as the positive control against 
which linker-engineered aggregates are compared. This is to determine if  
1) linker-engineered aggregates would re-model during culture into spheroids with 
features similar to those of mature spheroids formed naturally, 
2) the inter-cellular linker can accelerate the formation of mature 3D cultures for 
tissue engineering purposes. 
Mature spheroids are compact cultures of cells ~ 200-250 mm in diameter with the 
following features: development of cell-cell interactions,149, 150 secretion of extra-
cellular matrix,151-153 development of gradients of nutrient concentration and cell 
proliferation from the exterior to the centre,48-50, 59 and good cellular functions,27, 
154 and drug penetration resistance.50 Here we check the linker-engineered 




· Comparing the growth rate of linker-engineered aggregates and naturally-
formed spheroids 
· Structural characterisation of linker-engineered aggregates (of different ages) 
and comparing the structural features to those of a mature naturally-formed 
spheroid. These include 
o Morphological observation using H & E staining 
o Immunostaining for cell-cell interaction protein, E-cadherin 
o Immunostaining for ECM proteins fibronectin and laminin 
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o Hydroxyproline test for collagen content 
o BrdU labelling for proliferative cells 
o Staining for hypoxic regions in spheroids 
· Functional characterisation of linker-engineered aggregates and comparing 
the functions to those of a mature naturally-formed spheroid. These include 
o Albumin secretion 
o Cytochrome P450 1A1/2 enzymatic activity 
o Umbelliferone glucoronide transferase (UGT) enzymatic activity 
· Drug response of mature linker-engineered aggregates, and comparing the 
response to that of a mature naturally-formed spheroid  
o Drug penetration 
 
 
3.3 Specific Aim 3: To engineer reproducible 3D cell-dense micro-constructs 




The inter-cellular linker can be used in combination with micro-fabricated 





It is important for applications that we can reproducibly engineer the cellular 
constructs and the cell culture microenvironment. To do so, we utilised a 
microfluidic channel with a micro-fabricated pillar array132 to define the dimensions 
of the linker-engineered aggregates. The microfluidic system also helped to maintain 
a consistent and reproducible cell-culture microenvironment.73, 100 At the same time, 
we created a novel method for seeding and culturing mammalian cells at high 
density and three-dimensionally in microfluidic systems without the use of 
hydrogels. Conventionally, to support cells in 3D, various natural and synthetic 
hydrogels have been incorporated into microfluidic cell culture systems for cell 
encapsulation.132, 141, 155 However, there are several limitations associated with the 
use of hydrogels to effect 3D cell culture in microfluidic systems. Animal-derived 
hydrogels (e.g., collagen) can be variable in composition and properties,1, 94 while 
some synthetic hydrogels (e.g., poly(ethylene glycol) (PEG)) require cytotoxic ultra-
violet photo-polymerisation.139, 156, 157 Mass transport of oxygen and nutrients 
through dense hydrogels, which are required to mechanically withstand fluid 
perfusion in microfluidic systems, may also be inefficient.158 Furthermore, use of 
hydrogels may impose operational complexity such as sealing of the microfluidic 
channel after hydrogel incorporation156 or using hydrodynamic focusing for in situ 
gelation within the microfluidic channel.141, 142 More importantly, the use of 
hydrogels to encapsulate cells may not be ideal for forming 3D in vitro models that 
are cell-dense and ECM-poor.  
Here a combination of inter-cellular linker and a micro-fabricated pillar 
array in a microfluidic channel were used for the in situ formation and 
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immobilisation of 3D cellular aggregates in a microfluidic channel, such that the 
3D microfluidic cellular construct is: 
1) of reproducible dimensions, 
2) maintained in a consistent and reproducible cell culture microenvironment, 
3) relieved of hydrogel encapsulation, resulting in high cell packing density and 
simple operation previously not attainable with the use of hydrogels. 
 
Experimental design 
· Optimisation of the operational parameters of the 3D microfluidic cell 
culture system, including cell seeding density, extent of cell surface 
modification, inter-cellular linker concentration and the perfusion flow rate 
during cell culture. 
· Monitoring the cellular construct for viability and maintenance of the 3D cell 
morphology. 
· Functional assessment of the cellular construct with hepatic cell line C3A 
and primary rat mesenchymal bone marrow stem cells. 
· Demonstration of a potential application of the 3D microfluidic cell culture 





4. MATERIALS AND METHODS 
4.1 Evaluation of inter-cellular polymeric linker for engineering a 3D cell-
dense culture model 
All reagents were purchased from Sigma-Aldrich unless otherwise stated. 
4.1.1 Synthesis and characterisation of inter-cellular linker 
Synthesis and characterisation of PEI-hydrazide 
Thiol groups were first conjugated onto PEI (Mw = 1800 Da) by reacting with 2-
iminothiolane.159 Twenty milligrams of PEI was added to 15 mg of 2-
iminothiolane in 2 ml of distilled water and reacted for 2 h at room temperature. 
25.6 mg of E-maleimidocaproic acid hydrazide (EMCH Pierce, USA) in 1 ml PBS 
was added and reacted for 4 h at room temperature. EMCH contains maleimide 
groups and hydrazide groups.160 The maleimide group reacts with the thiol groups 
to form a thioether linkage, yielding PEI molecules with conjugated hydrazide 
groups (Figure 12). The final product was isolated by eluting through a PD-10 
column (Amersham Pharmacia Biotech AB, Piscataway, USA) with deionised 
water and freeze-dried.  
Ellman’s test was used to quantify the average number of hydrazides 
conjugated onto a PEI molecule (Uptima). According to the manufacturer’s 
protocol, 50 ml of the DTNB solution, 100 ml of Tris solution, and 840 ml of water 
was added into a cuvette (Plastibrands, BRAND, Germany) and placed into UV–
Vis spectrophotometer (UV-1201, Shimadzu, Japan) for a background scan. Ten 
microliter of sample solution was then introduced into the cuvette, mixed well and 
incubated for 5 min at room temperature; and the absorbance measured at 412 nm. 
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The average of the absorbance for each sample was calculated and divided by 
13,600 M-1 cm-1 (the extinction coefficient of the reagent) to obtain the molarity of 
the solution.  
 
Synthesis and characterisation of neutral hydrazide 
All solvents used were freshly distilled. Tetrahydrofuran (THF) and diethyl ether 
was dried from sodium in a recycling still using benzophenone as an indicator. 
Flash column chromatograph was performed with silica (Merck, 70–230 mesh). 1H 
NMR spectra were measured at 298 K on Bruker DPX 300 Fourier transform 
spectrometer. Chemical shifts were reported in d (ppm), relative to the internal 
standard of tetramethylsilane (TMS). Mass spectra were performed on VG 
Micromass 7035 spectrometer under electron spray ionisation (ESI). Neutral ester 
was obtained by condensation of methyl malonate with methyl acrylate.161 Methyl 
malonate (0.264 g, 2 mmol) and methyl acrylate (0.451 ml, 5 mmol, 2.5 equiv) 
were introduced to 10 ml-RBF containing 2.5ml of freshly distilled THF. Sodium 
hydride NaH (60 % in oil, 0.1 g, 2.5 mmol, 1.25 equiv) was added into the well-
stirred solution in portions. The solution was allowed to stir overnight at room 
temperature. The reaction mixture was worked up and extracted with ether. The 
ether extract was dried over sodium sulfate, concentrated and subsequent flash 
column chromatography (silica, hexane/EtOAc 6:1) yielded desired compound, 
tetramethylpentane-1,3,3,5-tetracarboxylate (0.529 g, 87 % yield). The neutral 
ester groups were then transformed into hydrazide groups by reacting with 
hydrazine hydrate162 (Figure 13). Neutral ester (86 mg, 0.283 mmol) was dissolved 
in MeOH (1 ml). Hydrazine hydrate (83.35 ml, 1.698 mmol, 6 equiv) was added 
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dropwise. The reaction was allowed to reflux for 8 h. Solvent was removed in 
vacuo. Residue was washed with hexane to afford product, pentane-1,3,3,5-
tetracarbohydrazide (82.5 mg, 96 % yield).  
 
Synthesis of Fluorescent PEI-hydrazide 
PEI-hy was tagged with a fluorescent probe as reported previously.163 PEI-hy was 
diluted to a concentration of 10 mg ml-1 with 0.1M sodium bicarbonate. Fifty 
microliter of Oregon Green 488 carboxylic acid, succinimidyl ester (Molecular 
Probes, USA) in DMSO at 10 mg ml-1 was added to the PEI-hy and reacted for 1 h 
in the dark at room temperature, followed by an additional incubation of 1 h in the 
dark. Un-reacted Oregon Green was removed by dialysis with MWCO 1000 
(Spectrum Laboratories) for 24 h at room temperature. The labelled PEI was then 
freeze-dried and stored at 4 °C.  
 
Cytotoxicity study of PEI-hy 
HepG2 cells were plated on 96-well microtitre plates at a density of 1.2 ´ 104 cells 
per well. After 24 h, PEI-hy in serum-free culture medium at different 
concentrations was added. Twenty four hours later, the total number of viable cells 
was measured using MTS assay: CellTiter96s Aqueous One Solution Reagent 
(Promega, Madison, USA), diluted five times in PBS, was added to the cells and 
incubated at 37 °C in the dark. After 3 h, the solution was collected, centrifuged 
and the absorbance of the supernatant was measured at 490 nm using a microplate 
reader Sunrise (Tecan, Switzerland). All absorbance reading were plotted as a 
percentage of the absorbance reading of the control group (incubated with culture 
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medium). Error bars represent the standard error of the mean (s.e.m.) of three 
experiments.  
 
Cytotoxicity study of NaIO4 
HepG2 cells were plated on 96-well microtitre plates at a density of 1.2 ´ 104 cells 
per well. After 24 h, NaIO4 of various concentrations were added for 15 min; and 
the cells were assessed for viability using the Trypan Blue exclusion test or 
fluorescence viability staining. Percentage viability was calculated by expressing 
the number of live cells as a percentage of the total number of cells. Error bars 
represent the s.e.m. of three experiments.  
 
4.1.2 Forming cellular aggregates using inter-cellular linker 
Formation and culture of the cellular aggregates 
Single HepG2 cells (1 million) were suspended in 1 ml cold sodium periodate or 
PBS (control) in 1.5 ml tubes and incubated at 4 °C in the dark. After 15 min, the 
cells were spun down (1000 rpm, 3 min) and washed with cold PBS. Thereafter, 
cold PEI-hy or neutral hydrazide or PBS (control) was added and the tubes were 
placed on an orbitron shaker (Model 260200, Boekel Scientific, US) to facilitate 
mixing of the cells and linker for aggregation to take place. The whole process was 
performed at low temperature (solutions kept on ice, shaker placed in the cold 
room) to minimise endocytosis of the NaIO4 or PEI-hy or neutral hydrazide during 
incubation with the cells. Cellular aggregates formed after 30 minutes of 
incubation with the linker were washed with PBS (spun down at a lower speed of 
1000 rpm for 30 s to minimise formation of a huge pellet of cellular aggregate). 
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Cellular aggregates recovered from 1 tube were re-suspended in 4 ml of fresh 
culture medium in 6 well dishes. The dishes were then placed on an orbital shaker 
(Spectra-teknik, USA) rotating at 50 rpm at 37 °C in a humidified environment 
with 5 % CO2. The orbital shaker was set at the minimum rotational speed required 
to prevent attachment of the cells on the bottom of the culture dishes. 
 
Formation and culture of the cellular aggregates with fluorescent PEI-hydrazide 
Aggregates were formed using 0.05 mM fluorescent PEI-hy on chemically 
modified HepG2 cells as mentioned in above. Presence of the fluorescent inter-
cellular linker was observed with an excitation wavelength of 488 nm and a 510–
530 nm band pass filter with Olympus Fluoview 300 confocal microscope. Images 
shown are 2D projections of scans up to a depth of ~ 60 mm from the bottom to the 
centre of the aggregates. The amount of fluorescent inter-cellular polymeric linker 
present on cell surfaces was quantified using the software ImagePro Plus as the 
ratio of the number of green pixels (amount of linker) to the number of blue and 
red pixels (number of cells), and expressed as a percentage of the ratio obtained on 
day 0. As the images do not represent entire scans through the aggregates, the data 
are only semi-quantitative estimates for comparison between different time points. 
At least 10 images were taken for every time-point for quantification. Error bars 
represent the s.e.m. of three independent experiments. 
 
4.1.3 Morphological observation of cells in cellular aggregates 
 
Fluorescence viability staining of the cellular aggregates 
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The cellular aggregates were incubated with 25 mM CellTrackerTMGreen or 
CellTrackerTMBlue (Molecular Probes, USA) and 25 mg ml-1 PI in culture medium 
for 30 min at 37 °C and then fixed with 3.7 % PFA for 30 min at room 
temperature; and kept in PBS until observation. Images of cell aggregates were 
taken with Olympus Fluoview 300 confocal microscope. Images shown are 2D 
projections of scans up to a depth of ~ 60 mm from the bottom to the centre of the 
aggregates. The images were quantified by calculating the ratio of the number of 
green pixels (live cells) to the total number of green and red pixels (total number of 
cells). As the images do not represent entire scans through the aggregates, the data 
are only semi-quantitative estimates for comparison between different time points. 
At least 10 images were taken for every time-point for quantification. Error bars 
represent the s.e.m. of three independent experiments. 
 
Proliferation (MTS) assay 
CellTiter96s Aqueous One Solution Reagent (Promega, Madison, USA), diluted 
five times in PBS, was added to the cells and incubated at 37 °C in the dark. To 
ensure sufficient penetration of the MTS reagent into the 3D aggregates for colour 
change to take place, an incubation of 3 hours was used. After 3 h, the solution was 
collected, centrifuged; and the absorbance of the supernatant was measured at 490 
nm using a SunriseTM microplate absorbance reader (Tecan, Switzerland). All 
readings were plotted as a percentage of the reading obtained at the first time point 
on day 0. Error bars represent the s.e.m. of three independent experiments. The 
control group consisted of single cells in suspension culture that were subject to 




Cellular aggregates were fixed in 3.7 % PFA for 30 min and permeabilised with 
0.5 % Triton-X for 15 min before staining with 0.2 mg ml-1 TRITC-Phalloidin 
(Invitrogen, Singapore) for 20 min at room temperature. Images of cell aggregates 
were taken with Olympus Fluoview 300 confocal microscope. Images shown are 
2D scans near the centre of the aggregates. 
 
Scanning electron microcopy 
Cellular aggregates were seeded onto cover slips placed in 24 well dishes for 1 h at 
37 °C for minimal attachment. Cellular aggregates attached to the cover slips were 
then washed and fixed with 3.7 % PFA for 30 min and post-fixed in 1 % OsO4 for 
1 h. Cellular aggregates were then dehydrated step-wise with ethanol (25 %, 50 %, 
75 %, 90 %, 100 %), dried in vacuum oven and sputter coated with platinum for 
viewing with the field-emission scanning electron microscope (JEOL, Japan).  
 
Hydroxyproline assay 
Cellular aggregates or cells grown on 2D monolayer for 24 h were lysed in 6M 
HCl at 110 °C for 24 h. The HCl was evaporated by placing the samples in open 
glass vials on a heating stage at 70 °C in the fume hood. The residue was dissolved 
in 200 ml of 1´ assay buffer, a 10´ dilution of the stock buffer. (the stock buffer: 
50 g citric acid monohydrate, 12 ml acetic acid, 120 g sodium acetate, 34 g sodium 
hydroxide, topped up to 1 litre with deionised water). One hundred ml of choramin-
T reagent was added to the mixture and incubated at room temperature for 20 min 
(Chloramin-T-reagent: 0.3525 g Chloramine T freshly dissolved in 5.175 ml water, 
6.5 ml m-propanol and 13.325 ml stock buffer). One hundred ml of dimethyl-
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aminobenzaldehyde (DMAB) reagent was then added to the mixture and incubated 
at 60 °C for 15 min (DMAB reagent: 3.75 g DMAB freshly dissolved in 15 ml n-
propanol and 6.5 ml perchloric acid). All chemicals were used without dilution. 
The resulting solution was then cooled and the absorbance measured at 540nm 
within 30 min. Collagen (PureCol, Inamed, USA) standard was used as positive 
control for calibration of a standard curve. The collagen content measured was 
normalised to the number of cells analysed by PicoGreen DNA quantification 
assay (below) and plotted as a percentage of the day 0 value. Error bars represent 
the s.e.m. of three independent experiments.  
 
DNA quantification assay 
Total cell number was quantified using Quant-iTTM PicoGreen dsDNA Assay Kit 
(Invitrogen). Cellular aggregates were lysed in 0.1 % SDS solution. Fifty mililitres 
of this mixture was diluted to 500 ml with PBS and reacted with the DNA dye 
(diluted 200´ in PBS) for 5 min in the dark at room temperature. The DNA dye 
binds all double-stranded DNA, including DNA of apoptotic bodies and dividing 
cells, and hence is only an estimate of the total cell number. The mixture was then 
excited at 480 nm and the fluorescence read at 520 nm. A calibration curve with 
known cell numbers was used for quantification.  
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4.2 Biological characterisation of linker-engineered aggregates  
4.2.1 Structural characterisation of linker-engineered aggregates and naturally-
formed spheroids  
Formation of naturally-formed spheroids 
C3A cells were seeded at a density of 2 million cells in 4 ml culture medium per 
well in a 6-well dish on an orbital shaker (Spectra-teknik, USA) rotating at 50 rpm at 
37 °C in a humidified environment with 5 % CO2.  
 
Formation of linker-engineered aggregates 
C3A cells were aggregated in the same way as previously described in Section 
4.1.2. 
 
Assessment of the growth rate of linker-engineered aggregates and naturally-formed 
spheroids 
The growth of linker-engineered aggregates and naturally-formed spheroids was 
quantified by measuring their diameters on images taken with a phase contrast 
microscope (Olympus, Japan). At least 10 images were taken for every time-point 





Samples of linker-engineered aggregates were taken on Day 3, 5, 7, 8, 9 and 10 days 
and samples of naturally-formed spheroids are taken on Day 16. Samples were fixed 
with 3.7 % PFA for 2 h at room temperature and stored in PBS at 4 °C until 
preparation for cryosections. 
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Preparation of cryosections 
Samples were immersed in 30 % sucrose overnight at 4˚C and placed into a cryo-
mould filled with cryo-embedding compound (OCT), snapped frozen in a slush of 
dry ice and sectioned at 5 mm using a cryostat (Leica CM3050S, Leica 
Microsystems, Wetzlar, Germany). 
 
Preparation of paraffin sections 
Samples were transferred from fixative to lens paper. The lens paper was wrapped 
around the samples to prevent loss during processing. Samples were fixed in 10 % 
neutral buffered formalin (Sigma) and processed into wax. 5 μm sections were cut 
from the wax block using a microtome (Leica RM2235, Leica, Singapore) and 
transferred to poly-lysine coated glass slides (Menzel-Glaser, Poly-lysine).  
 
De-paraffinisation procedure 
Paraffin sections were dewaxed by immersion in 100 % xylene (Merck, Singapore) 
for 3 ´ 5 min, followed by 3 ´ 5 min in 100 % ethanol (Far East Distilled Industry, 
Singapore).  After dewaxing, endogenous peroxidase activity was blocked by 
incubation in methanol (Merck, Singapore) containing 3 % hydrogen peroxide 
(Merck, Singapore), and then rehydrated by a series of 5 min immersions in 95 %, 
80 %, 70 % ethanol and finally in running tap water. Sections were then placed into 
a container filled with unmasking solution pH 6 (Dako) and heated for 20 min in a 




Hematoxylin and Eosin staining 
Routine hematoxylin and eosin staining was carried out on paraffin sections 
followed by mounting with a glass coverslip and synthetic resin.  
 
Immunostaining 
The following steps were all carried out on cryo-sections in a humidified chamber. 
The PBS was replaced with a blocking solution of 10 % goat serum 
(DakoCytomation) in PBS for 20 min, followed by 1-h incubation with the desired 
primary antibody diluted in PBS. Primary antibodies (Sigma) used include mouse 
anti-human E-cadherin (1000 ´), mouse anti-human fibronectin (500 ´) and mouse 
anti-human laminin (500 ´). The sections were washed for 10 min in running tap 
water then incubated for 30 min with the secondary antibody – labelled polymer- 
HRP anti mouse Envision Kit (Dako Cat K4007), followed by washing in running 
tap water for 10 min. DAB substrate solution from labelled polymer-HRP anti 
mouse Envision Kit (Dako Cat K4007) was placed on the sections for 30 s to 2 min.  
The slides were then placed into water to stop the staining reaction before 
counterstaining with haematoxylin for 2 min haematoxylin and washed in running 
tap water for 5 min.  The sections were then dehydrated by a series of 5-min 
immersions in 70 %, 80 %, 90 %, 3 ´ 100 % ethanol followed by 3´ xylene.  
Coverslips were mounted on top of the sections using DPX (CellPath, Singapore) 
and left to dry overnight. Negative controls were treated in the same way without 
primary antibody incubation. The same negative control was used for 




Quantification of the immunostaining was carried out with software ImagePro Plus. 
Digital images were segmented into blue and brown pixels (refer to Appendix A) 
and the number of brown pixels (protein of interested) and number of blue objects 
(nuclei) were counted. The level of expression of the protein of interest is expressed 
as the total number of brown pixels divided by the number of nuclei, in arbitrary 
units. At least 10 images were taken per time-point per experiment for 
quantification. Error bars represent the s.e.m. of three independent experiments. 
 
Hydroxyproline assay 
This method is described in section 4.1.3. 
 
Bromodeoxyuridine (BrdU) labelling 
BrdU labelling was carried out with the BrdU Labelling and Detection Kit II 
(Roche). Samples were incubated with BrdU reagent (Roche) at 10 mmol L-1 for 1 h, 
fixed with 70 % ethanol for 20 min at – 20 °C, and kept in PBS at 4 °C until cryo-
sectioning. Cryo-sections were then incubated with anti-BrdU antibodies (Roche), 




Samples were incubated with pimonidazole HCl (Natural Pharmacia International, 
Inc) at 200 mmol L-1 for 2 h at 37 °C. They are then washed and fixed in 3.7 % PFA 
for 2 h at room temperature, and stored in PBS at 4 °C until cryo-sectioning. 
Sections are then detected for pimonidazole with anti-pimonidazole antibody (2000 
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´ dilution) and visualised with indirect immunoperoxidase staining according to the 
manufacturer’s protocol. 
 
4.2.2 Functional assessment of linker-engineered aggregates and naturally-
formed spheroids 
Albumin secretion 
The amount of albumin secreted into the culture medium was determined by a 
sandwich enzyme-linked immunosorbent assay, using a human albumin ELISA 
quantification kit (Bethyl Laboratories, Montgomery, TX). The standard curve was 
established using human albumin provided in the kit. Albumin production is 
expressed as total albumin (mg) collected in culture medium over 24 h normalised to 
the total number of cells obtained from the DNA quantification (described in section 
4.1.3). Error bars represent the s.e.m. of three independent experiments. 
 
Cytochrome P450 enzymatic activity 
Enzymatic activity was determined by incubating cellular aggregates and mature 
spheroids in 40 µM of 3-cyano-7-ethoxycoumarin (CEC) (Molecular Probes, OR, 
USA) in culture medium for 3 h. The medium was collected and the metabolic 
product, 3-cyano-7-hydroxycoumarin (CHC), was analysed using capillary 
electrophoresis with laser induced fluorescence (CE-LIF) detection (Prince 
Technologies B.V., Netherlands) at an excitation wavelength of 325 nm.164 Error 
bars represent the s.e.m. of three independent experiments. 
 
UDP-glucuronyltransferase (UGT) enzymatic activity 
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Enzymatic activity was determined by incubating cellular aggregates and mature 
spheroids in 100 µM of 4-methylumbelliferone (4-MU) (Merck, Singapore) in 
culture medium for 4 h. The medium was collected and the metabolic product, 4-
methylumbelliferyl glucuronide (4-MUG), was analysed using capillary 
electrophoresis with laser induced fluorescence (CE-LIF) detection (Prince 
Technologies B.V., Netherlands) at an excitation wavelength of 325 nm.164 Error 
bars represent the s.e.m. of three independent experiments. 
 
DNA quantification assay 
All functional data was normalised to total cell number quantified using the using 
the Quant-iTTM PicoGreen dsDNA Assay Kit (Invitrogen), described in 4.1.3. 
 
4.2.3 Drug response of cells in cellular aggregates 
Drug Treatment 
Linker-engineered aggregates (7-day old), naturally formed spheroids and confluent 
2D cultures of C3A were tested with doxorubicin (Sigma), also known as 
adriamycin commercially. Peak plasma concentration (PPC), the highest level of 
drug that can be obtained in the blood following multiple doses, of doxorubicin was 
reported to be 0.4 mg mL-1.165 Concentrations of 0.1, 1, 5 and 10´ the PPC were used 
for the experiment, i.e., 0.04, 0.4, 2 and 4 mg mL-1. Samples were incubated for 24, 
48 and 72 h. Thereafter, drug penetration was studied. 
 
Drug Penetration 
Samples were incubated with 25 mM CellTrackerTM Blue (Molecular Probes, 
USA), which stains live cells blue, and 250nM of Sytox GreenTM (Molecular 
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Probes, USA), which stains dead cells nuclei green, in culture medium for 30 min 
at 37 °C and imaged immediately with confocal microscope (Carl Zeiss). 
Doxorubicin is auto-fluorescent,166 and was excited with laser wavelength of 543 
nm and its emission collected with a 590 nm long pass filter. Images shown are 2D 
projections of scans up to a depth of ~ 60 mm from the bottom to the centre of the 
spheroids. Drug penetration was quantified with analysis of the confocal images 





4.3 Engineering 3D cell-dense micro-constructs in a microfluidic system 
4.3.1 Design, fabrication and operation of the microfluidic system 
Microfluidic device fabrication 
Microfluidic channels with a micro-fabricated pillar array were designed using 
AutoCAD (Autodesk, USA) (Figure 42 a). The micro-fabricated pillar array 
(hereafter referred to as “micropillars”) was designed to confine the dimensions of 
linker-engineered aggregates, resulting in formation of reproducible 3D cell-dense 
micro-constructs for applications.  The dimensions of the microfluidic channel 
were 1 cm (length) ´ 600 mm (width) ´ 100 mm (height); and each microfluidic 
channel has two inlets and one outlet. An array of 30 ´ 50 mm elliptical 
micropillars with a 20 mm gap size is situated in the center of the microfluidic 
channel, bounding a cell residence compartment that is 200 mm wide (Figure 42 c). 
Silicon templates were fabricated by standard deep reactive ion etching (DRIE) 
process (Alcatel, France). The microfluidic channels were then obtained by replica 
molding poly(dimethylsiloxane) (PDMS) (Dow Corning, USA) on the silicon 
templates. The PDMS structures were plasma-oxidised in oxygen plasma for 1 min 
(125W, 13.5 MHz, 50 sccm, and 40 millitorr) for irreversible bonding to glass 
coverslips before connecting to fluidic components (Upchurch, USA). One inlet of 
the microfluidic channel was connected to a cell reservoir, which comprised of a 
two-way valve with a luer connection (Cole–Palmer, USA) coupled to a 22G 
stainless steel hypodermic needle (Becton–Dickinson, USA) (Figure 42 b). The 
other inlet and outlet are for cell culture medium perfusion. The entire set-up was 
sterilised by autoclaving at 105 °C for 30 min.  
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Cell seeding in 3D microfluidic cell culture system (3D-mFCCS) 
Cells were first modified with 0.5 mM of sodium periodate (NaIO4) (Sigma) in test 
tubes at 4 °C in the dark. Cell seeding was performed by withdrawing a suspension 
(50 ml) of modified cells (6 million ml-1) and dissolved inter-cellular linker (6 mM 
PEI-hy) from the cell reservoir, via the outlet using a withdrawal syringe pump at a 
flow rate of 0.03 ml h-1. Upon filling up of central cell compartment, the cell 
reservoir was closed and culture medium infused from the inlet at a flow rate of 
0.03 ml h-1.  
 
Perfusion culture in 3D-mFCCS 
The cells were cultured in a one-pass perfusion manner with a syringe pump 
(Cole–Palmer) at 0.03 ml h-1. The microfluidic system was placed onto a heating 
plate (MEDAX GmbH & Co. KG, Germany) maintained at 37 °C throughout the 
culture period in a sterile hood. Sixty mM of Hepes buffer (GIBCO, Invitrogen, 
USA) was added to the culture medium to maintain its pH at 7.4 – 7.6.  
 
4.3.2 Characterisation of cell-dense micro-constructs  
Cell viability staining 
Cell viability was assessed by perfusing 5 mM of Calcein AM (Molecular Probes, 
USA) and 25 mg ml-1 of propidium iodide at 0.5 ml h-1 for 30 min and immediate 
monitoring by confocal microscopy (Fluoview 300, Olympus, Japan). Images 
shown are 2D projections of scans up to a depth of ~ 60 mm from the bottom to the 
centre of the 3D-mFCCS. As the images do not represent entire scans through the 
3D-mFCCS, the data are only semi-quantitative estimates for comparison between 
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different flow rates in Figure 46. At least 10 images along the length of the 3D-
mFCCS were taken for every flow rate for quantification. Error bars represent the 




F-actin distribution in all cell types was assessed after 3 days of perfusion culture 
in the gel-free 3D-mFCCS. In situ F-actin staining was performed after fixation 
with 3.7 % paraformaldehyde (PFA) (30 min) by infusing the microfluidic channel 
with 0.5 % Triton-X 100 (USB Corp, USA) (30 min), 0.2 % bovine serum albumin 
(BSA) (30 min), 0.2 mg ml-1 of TRITC-phalloidin (Invitrogen, Singapore) (20 
min) and 1´ PBS (15 min) at 0.5 ml h-1. 2D monolayer cultures were fixed with 
3.7 % PFA (15 min) and stained by incubating with 0.5 % Triton-X 100 (10 min), 
0.2 % BSA (15 min), and 0.2 mg ml-1 of TRITC-phalloidin (20 min) Samples were 
view with confocal microscopy (Fluoview 300, Olympus, Japan). Images shown 
are 2D scans near the centre of the 3D-mFCCS or at the plane of cell attachment 
with actin stress fibres for 2D cultures. 
 
Scanning electron microscopy 
SEM samples were prepared by bonding the PDMS microfluidic channels onto a 
polyethylene (PE) film (Diversified Biotech, USA) instead of a glass coverslip 
(refer to Appendix B). The samples were fixed with 3.7 % PFA before the PE film 
was peeled off to expose the microfluidic channel for SEM processing. Samples 
were sequentially dehydrated with ethanol series (25, 50, 75, 95 and 100 %), and 
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then platinum-sputtered (20 mA, 60 s) before viewing with a field-emission 
scanning electron microscope (JEOL, Japan).  
 
4.3.3 Functional assessment of cell-dense micro-constructs  
Functional assessment of C3A 
All functional data were normalised to cell number (DNA content) quantified using 
PicoGreen assay (Molecular Probes, USA) according to the manufacturer’s 
protocol. Albumin production was quantified with a human albumin ELISA 
quantification kit (Bethyl Laboratories Inc, USA) in culture medium collected. For 
comparison with 2D culture, the culture medium of a confluent 2D monolayer 
incubated in static wells was collected for albumin quantification. Albumin 
production is expressed as total albumin (mg) collected in culture medium per 
million cells over 24 h. UDP-glucuronyltransferase (UGT) activity of C3A 
cultured in the gel-free 3D- mFCCS was determined by infusing 100 mM of 4-
methylumbelliferone (4-MU) (Sigma, Singapore) for 6 h at 0.05 ml h-1. The 
perfusate (300 ml) was collected and the metabolic product, 4-methylumbelliferyl 
glucuronide (4-MUG), was analysed using capillary electrophoresis with laser 
induced fluorescence (CE-LIF) detection (Prince Technologies B.V., Netherlands) 
at an excitation wavelength of 325 nm.164 UGT activity in confluent 2D monolayer 
cultures was determined by incubating the samples with 300 ml of 100 mM of 4-
MU for 6 h before CE-LIF analysis. 4-MUG production is expressed as total 4-
MUG (pmol) collected in culture medium per million cells over 6 h. Error bars 
represent the s.e.m. of three independent experiments. 
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von Kossa staining 
BMSCs after 1 week of osteogenic induction were stained for calcium salt deposits 
by von Kossa staining. von Kossa samples were prepared by bonding the PDMS 
microfluidic channels onto a PE film instead of a glass coverslip, fixed with 3.7 % 
PFA before the PE film was peeled off to expose the microfluidic channel. 
Effective washing could be achieved to avoid false positive staining. von Kossa 
staining was carried out with static incubation of the following: 5 % silver nitrate 
solution (45 min), distilled water (DIW) (3 ´ 5 min), 5 % sodium bicarbonate in 
3.7 % PFA solution (8 min), DIW (3 ´ 5 min), 5 % sodium thiosulfate (5 min) and 
DIW (3 ´ 5 min). Likewise, von Kossa staining was performed in 2D monolayer 
cultures after 1 week of osteogenic induction. Samples were viewed under bright 
field transmission light microscopy (Olympus, Japan). 
 
4.3.4 Drug penetration studies on cell-dense micro-constructs 
C3A cells were seeded into the 3D-mFCCS and cultured for 7 days. The auto-
fluorescent anti-cancer drug, doxorubicin (4 mg mL-1) was then infused into the 3D-
mFCCS together with the cell viability dye, Calcein AM (5mM) (Molecular Probes, 
OR, USA) and mounted onto a confocal microscope (Olympus, Japan) for live 
imaging. Images shown are 2D projections of scans up to a depth of ~ 60 mm from 
the bottom to the centre of the 3D-mFCCS.  Drug penetration was quantified using 
image analysis software, ImagePro Plus, by counting the number of red pixels. Total 
cell viability was quantified by counting the total number of green pixels for each 
time-point and expressing it as a percentage of the number of green pixels at the 
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beginning of the experiment. Spatial information on drug penetration was obtained 
by summing up the number of red pixels along the cross-section of the 3D-mFCCS. 
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4.4 Cell Culture 
HepG2 cells (ATCC, USA), a human heptocellular carcinoma derived cell line, 
were cultured in Dulbecco’s modified Eagle’s medium (GIBCO, Invitrogen, USA) 
supplemented with 10 % FCS (Hyclone, USA), 1.5 g L-1 glucose, 100 units ml-1 
penicillin, 100 g ml-1 streptomycin, 1.3 g L-1 sodium bicarbonate and 1.2 g L-1 
Hepes (GibcoBRL, Life Technology, USA). The cells were cultured at 37 °C in a 
humidified environment with 5 % CO2.   
C3A cells (ATCC, USA), a sub-clone of HepG2, were cultured in 
Minimum Essential Medium supplemented with 10 % FCS, 1.5 g L-1 sodium 
bicarbonate, 1 mM sodium pyruvate, 100 units ml-1 penicillin and 100 g ml-1 
streptomycin.    
A549 cells (ATCC, USA), a human lung epithelial carcinoma cell line, 
were cultured in F12K supplemented with 10 % FCS, 1.5 g L-1 sodium bicarbonate, 
2 mM L-glutamine, 100 units ml-1 penicillin and 100 g ml-1 streptomycin.    
Bone marrow stem cells were harvested from the bone marrow of male 
Wistar rats and cultured in low glucose Dulbecco’s Modified Eagle’s Medium 
supplemented with 10 % FCS and 1.5 g L-1 sodium bicarbonate. Osteogenic 
medium was prepared by supplementing basal medium with 100 nM 
dexamethasone, 50 mM ascorbic acid 2-phosphate and 10 mM b-glycerophosphate 




5. RESULTS  
5.1 Evaluation of inter-cellular polymeric linker for engineering a 3D cell-
dense culture model 
In this section, we describe the building of a system of 3D culture by aggregating 
cells with polymeric molecules that we termed “inter-cellular linker”. The inter-
cellular linker is based on polyethyleneimine (PEI), and the primary amine groups 
on the PEI arms were modified to yield hydrazides which can react with the 
aldehyde handles on chemically modified cell surfaces to form 3D cellular 
aggregates. The human hepatic cell line, HepG2, was used as a model system for 
most the studies unless otherwise specified. 
 
5.1.1 Synthesis and characterisation of inter-cellular linker 
Synthesis and characterisation of PEI-hy and neutral hydrazide  
We synthesised an inter-cellular polymeric linker based on non-toxic low 
molecular-weight polyethyleneimine (PEI, molecular weight ~ 1800 Da), which 
contained multiple primary amines on a positively charged backbone. Thiols were 
first conjugated onto the amines; and hydrazide groups were then conjugated onto 
the thiols to obtain PEI-hydrazide (PEI-hy, Figure 12). Ellman’s test was used to 
quantify the number of free thiols present on PEI after the two reactions to 
determine the number of hydrazide groups conjugated onto a PEI molecule. There 
were 3.85 thiols per PEI molecule after thiolation, and 0.12 thiol groups per PEI 
molecule after conjugating hydrazides. Hence on average, there were 
approximately 3.73 hydrazides per PEI molecule on the final product PEI-hy.  
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Figure 12 Schematic diagram of the synthesis of PEI-hy. (a) Reaction of PEI with 2-
iminothiolane results in conjugation of thiols onto the primary amines on PEI. 
(b) Reaction with EMCH conjugates hydrazides onto the thiols, yielding PEI-
hy.  
 
To test if the positively charged backbone of PEI-hy played a role in aggregating 
cells, a similar polymeric linker with a neutral backbone was synthesised. A 
neutral polymeric backbone with four ester groups was obtained by condensation 
of methyl malonate with methyl acrylate. The ester groups were then transformed 
into hydrazide groups by reacting with hydrazine hydrate to obtain neutral 
hydrazide (Figure 13). NMR and mass spectroscopy verified the structure of the 
neutral ester and neutral hydrazide. NMR data of neutral ester showed the presence 
of methylene protons and methyl ester protons with ratio 2:2:3:3. The identity of 
the neutral ester was also confirmed using mass spectroscopy (ESI) m/z 304.9 
(M+H+). Methylene protons appeared in 1H NMR spectrum of neutral hydrazide 
and were shifted to higher magnetic field. Integrated value corresponded to ratio of 
1:1 to each methylene proton groups. The identity of the neutral hydrazide was 
also confirmed using mass spectroscopy (ESI) m/z 304.9 (M+H+). Thus, the 
desired neutral hydrazide with four hydrazide groups was successfully obtained.  
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Figure 13 Schematic diagram of the synthesis of neutral hydrazide. (c) Condensation of 
methyl malonate with methyl acrylate results in a neutral polymer with 4 
ester groups. (d) Reaction with hydrazine hydrate converts the ester groups to 
hydrazides, yielding neutral hydrazide.  
 
5.1.2 Forming cellular aggregates using inter-cellular linker 
Effective cellular aggregation requires a positively charged linker backbone  
To assess the ability of PEI-hy to aggregate chemically modified cells, cells 
unmodified (control) and modified with 1 mM sodium periodate (NaIO4) were 
suspended in 0.1mM PEI (control) and PEI-hy. Sodium periodate oxidises the 
sialic acid residues of glycoproteins on cell membranes, generating aldehydes 
handles for reacting with the hydrazides on PEI-hy.66 Unmodified cells without 
aldehyde handles on cell surfaces could not be aggregated with either PEI or PEI-
hy (Figure 14a, b). Modified cells formed small aggregates with PEI (Figure 14c) 
but large aggregates with PEI-hy (Figure 14d). This observation shows that both 
PEI-hy and modified cells are necessary for efficient cellular aggregation. We also 
hypothesised that the charge interaction between the modified cell-surfaces (made 
more negatively charged with aldehydes) and the PEI molecules (positively 
charged backbone) played a role in facilitating cellular aggregation. Indeed, the 
neutral hydrazide could not aggregate modified cells at all (Figure 14e). While 
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PEI-hy with 3.73 hydrazide arms was very effective, neutral hydrazide could not 
induce cellular aggregation even though it possessed four hydrazide arms. Thus 
charge interaction between the positively charged PEI-hy molecules and the 
negatively charged cell surfaces plays a critical role in inducing cellular 
aggregation likely by concentrating the PEI-hy molecules onto the cell surfaces for 
the chemical reaction between hydrazides and aldehydes to occur.  
 
 
Figure 14 Cellular aggregation requires both chemically modified cells and positively-
charged PEI-hy. a) Unmodified cells in PEI, and b) unmodified cells in PEI-
hy are not aggregated. c) Modified cells in PEI form small aggregates. d) 
Modified cells in PEI-hy form large aggregates. e) Modified cells in neutral 
hydrazide are not aggregated. HepG2 cells were modified with 1.0 mM 
NaIO4 and suspended in 0.10 mM of PEI or PEI-hy or neutral hydrazide. 
Scale bar: 60 mm. 
 
Forming viable cellular aggregates with inter-cellular polymeric linker  
To ensure that the cellular aggregates formed were viable, a biocompatibility test 
of PEI-hy at different concentrations was conducted using the MTS assay, which is 
a colorimetric method for determining the number of viable cells. The absorbance 
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readings were normalised to that of the control group (incubated with culture 
medium without PEI-hy). When cells were incubated with PEI-hy at 
concentrations £ 0.1 mM for 24 h, cell viability of ≥ 80 % was observed (Figure 
15) whereas all cells died when incubated with 1 mM of PEI-hy. PEI-hy is thus 
non-toxic to cells at concentrations £ 0.1 mM.  
 
 
Figure 15 Biocompatibility test of PEI-hy. Percentage viability of HepG2 cells after 
incubation with PEI-hy at different concentrations.  
 
To assess the effect of modifying the cell-surface glycoproteins with NaIO4, cell 
viability assays (trypan blue exclusion test and fluorescence viability staining with 
CellTracker Green and Propidium Iodide) were conducted on cells modified with 
different concentrations of NaIO4 (Figure 16). Percentage viability was calculated 
by expressing the number of live cells as a percentage of the total number of cells. 
When cells were modified with NaIO4 of concentrations £ 1 mM, the cells showed 
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≥ 80 % viability. At 10 mM of NaIO4, fluorescence viability staining measured 
only 20 % viability while the trypan blue exclusion test measured 70 % viability. 
The fluorescence viability staining method might be more sensitive than the trypan 
blue exclusion test so that it was subsequently used for assessing cell viability. 
Modification of cell surfaces by NaIO4 at concentrations £ 1 mM did not affect cell 
viability. We tested a range of conditions within the biocompatible window (£ 0.1 
mM PEI-hy and £ 1 mM NaIO4) for aggregating cells. With PEI-hy and NaIO4 
concentrations £ 0.001 mM and £ 0.125 mM, respectively, less than 10 % of cells 
could form aggregates containing >10 cells. With PEI-hy concentration between 
0.01 and 0.10 mM, and NaIO4 concentration of 0.50 mM, 75 – 90 % of cells could 
form aggregates containing ≥ 10 cells. When cells were treated with 0.01 mM PEI-
hy and 0.50 mM NaIO4, 76.0 ± 1.7 % of cells aggregated and 69.2 ± 4.5 % of the 
cells were viable (Figure 19). This condition had been used to successfully 
aggregate a variety of cell types, including HepG2 (Figure 18), primary porcine 
hepatocytes and rat bone marrow stem cells, and other cell-lines such as HeLa and 
U251 (Figure 17).  
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Figure 16 Biocompatibility test of NaIO4. Percentage viability of HepG2 cells after 
incubation with NaIO4 at different concentrations measured with the Trypan 
Blue exclusion assay and fluorescence viability staining.  
 
                
Figure 17 Different cell types were successfully aggregated with 0.01 mM PEI-hy and 
0.50 mM NaIO4, including (a) Primary rat bone marrow stem cells (b) 
primary porcine hepatocytes and c) HeLa and (d) U251 cell lines. Scale bar: 
50 mm. 
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5.1.3 Culture of cellular aggregates 
Cell proliferation in the aggregates  
Cellular aggregates formed after incubation with the inter-cellular linker for 30 
minutes were washed with PBS and cultured in fresh culture medium. To evaluate 
the fate of the cells aggregated with the inter-cellular polymeric linker, the viability 
of the cellular aggregates was assessed over a 7-day culture period using 
fluorescence viability staining (Figure 18) with CellTrackerTM Green and PI. The 
cells exhibited an initial viability of 69.2 ± 2.6 % immediately after aggregation. 
By day 2 the viability had climbed to 91.5 ± 0.2 %, and by day 7 to 96.6 ± 1.0 % 
(Figure 19). This increase in cell viability was likely due to proliferation of the 
cells in the aggregates. MTS assay was performed to check cell proliferation by 
measuring the total cell number at different time points during the 7-day culture. 
The cell number doubled by day 2 (214 ± 31 %, Figure 20); and the cell number 
was more than eight times that of the initial (846 ± 41 %) by day 7 in culture. In 
the control group where single cells were cultured in suspension under the same 
condition, the cell number increased after 1 day (193 ± 2 %) but quickly dropped 
to only 16 ± 5 % by day 5 and 11 ± 5 % by day 7. This suggests that anchorage-
dependent HepG2 cells survive poorly as single cells in suspension culture; but can 




Figure 18 Proliferation of HepG2 cells in aggregates during a 7-day culture. (A) 
Confocal images of cellular aggregates at various time- points indicate that 
the aggregates grow in size with increasing percentage of viable cells over 
time during a 7-day culture. (a) Day 0, (b) Day 1, (c) Day 2, (d) Day 3, (e) 
Day 5, (f) Day 7. Scale bar: 50 mm. 
 
          
 
Figure 19 Quantification of percentage viability of the cells in aggregates with software 
ImagePro Plus on images in Figure 18 supports the observation.  
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Figure 20 Total cell number in the cellular aggregates, measured using MTS assay and 
plotted as a percentage of the initial cell number, increased over time 
indicating cell proliferation. Solid line represents cell proliferation in 
aggregates while dotted line represents unaggregated single cells control.  
 
Maintenance of 3D cell morphology 
Actin distribution was visualised in the aggregated cells to investigate whether 
these cells could maintain their 3D cell morphology. Cells in the aggregates indeed 
exhibited a cortical actin distribution typical of 3D morphology throughout the 7-
day culture (Figure 21), in contrast with the actin distribution in 2D cultured cells 
with stress fibers throughout the cytoplasm (Figure 21f, inset). The cells were 
loosely packed on day 0 (Figure 21a), but formed tight cell–cell contacts after 1 




Figure 21 Confocal images of actin distribution in HepG2 cellular aggregates at various 
time-points during a 7-day culture, showing the maintenance of 3D 
morphology of the cells. (a) Day 0, (b) Day 1, (c) Day 2, (d) Day 3, (e) Day 
5, (f) Day 7. Inset: Actin distribution in cells cultured as 2D monolayer. Scale 
bar: 20 mm. 
Aggregate compaction and ECM deposition in 7-day culture 
The compaction of the cellular aggregates was observed over time in culture 
(Figure 22). The aggregated cells formed a compact spheroid-like structure with 
blurring cell–cell boundaries by day 2 (Figure 22c). Subsequently, the aggregates 
grew larger while remaining compact (Figure 22 (d–f)). The aggregate compaction 
was more obvious in the SEM images (Figure 23) where the individual cells on 
day 0 were distinct with large inter-cellular spaces, whereas the cells on day 2 were 
closer to one another (Figure 23 (a–c)). Interestingly, fibrous ECM deposition was 
observed and filled up the inter-cellular spaces from day 3 onwards (Figure 23d), 
likely responsible for the indistinguishable cell–cell boundaries in Figure 22c). 
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This ECM covering then grew thicker and more fibrous. By day 7, ECM 
completely covered the entire aggregate such that individual cells could not be 
identified (Figure 23f). To quantify the amount of ECM secreted by the cellular 
aggregates, the collagen content of the cellular aggregates was measured using 
hydroxyproline assay and normalised to total cell number estimated using DNA 
quantification. There was a 25 ± 7 % increase in collagen content of the cellular 
aggregates from day 0 to day 3, and a 75 ± 23 % increase by day 7 (Figure 24), 
correlating the fibrous deposition observed on cellular aggregates in Figure 23 with 
collagen secreted by the cells. The aggregated cells can grow closer to compact the 
aggregates and secrete ECM to support the cells as they proliferate in this 3D 
culture over time. The increasing compactness of the cell aggregates (Figures 21 
and 22) and the deposition of fibrous ECM on the surfaces of the cell aggregates 
(Figures 23 and 24) might be the consequence of the natural cellular remodelling in 
the aggregates or interaction with inter-cellular polymeric linker. 
 
 
Figure 22 Phase contrast images of HepG2 cellular aggregates, showing the compaction 
of the aggregates during culture as illustrated by the blurring of cell-cell 
boundaries. (a) Day 0, (b) Day 1, (c) Day 2, (d) Day 3, (e) Day 5, (f) Day 7. 
Scale bar: 60 mm. 
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Figure 23 Scanning electron microscopy images of HepG2 cellular aggregates, showing 
the compaction of cells and deposition of ECM into the inter-cellular spaces 
and eventually covering the entire aggregate. (a) Day 0, (b) Day 1, (c) Day 2, 
(d) Day 3, (e) Day 5, (f) Day 7. . Scale bar: 5 mm. 
 
           
Figure 24 Relative amount of collagen secreted by HepG2 cells cultured as cellular 
aggregates during a 7-day culture, expressed as a percentage of the collagen 
secreted on day 0.  
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Disappearance of the inter-cellular polymeric linker from cell surfaces in culture 
We investigated the fate of the inter-cellular polymeric linker on cell surfaces. 
Fluorescent dyes were conjugated onto the PEI-hy and detected with confocal 
microscopy. The inter-cellular polymeric linker appeared as green fluorescent rings 
around the cells very clearly on day 0 (Figure 25a) but gradually disappeared over 
time (Figure 25 (b–f)). In the control experiment where cellular aggregates were 
fixed immediately after aggregation and subjected to the same culture conditions 
for 7 days, the green fluorescent rings remained intact on cell surfaces over time 
(Figure 25 (f), inset). Therefore, the disappearance of the fluorescent PEI-hy from 
the cell surfaces (Figure 25) is not due to photo-bleaching or other possible 
damages to the fluorophore under the culture conditions. The half-life of the inter-
cellular polymeric linker on cell surfaces was only 2 days (Figure 26); and the 
inter-cellular polymeric linker had almost completely disappeared from the cell 
surfaces by day 5. Therefore the inter-cellular polymeric linker is transient and the 
cellular aggregates can maintain their 3D integrity in culture likely via the natural 
cellular remodelling and ECM secretion independent of the inter-cellular 
polymeric linker.  
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Figure 25 Confocal images of HepG2 cells aggregated with fluorescent PEI-hy. Cells 
were counter-stained blue (live cells) and red (dead cells). (a) Day 0, (b) Day 
1, (c) Day 2, (d) Day 3, (e) Day 5, (f) Day 7. Inset: Image of a control cellular 
aggregate acquired on Day 7 where cells had been fixed immediately after 
aggregation on Day 0. Scale bar: 50 mm. 
 
       
Figure 26 Quantification of the amount of fluorescent inter-cellular polymeric linker 
remaining on cell surfaces over time with software ImagePro Plus using 
images from Figure 25. 
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5.2 Biological characterisation of linker-engineered aggregates  
In this section, we describe biological characterisation of the cellular aggregates, 
which we term “linker-engineered aggregates”, formed using the inter-cellular 
linker. The objective is to verify that the engineering process did not alter the cells’ 
ability to remodel during culture to display phenotypes of mature 3D cultures, e.g. 
mature 3D spheroids. Here, the term “mature spheroids” is used to describe  
compact aggregates of cells that possess the following features: development of 
cell-cell interaction, secretion of extra-cellular matrix,151-153 development of 
gradients of nutrient concentration and cell proliferation from the exterior to the 
centre,49, 50 good cellular functions,27, 154 and drug penetration resistance.50 Hence 
we assessed the linker-engineered aggregates for these features and compared them 
to mature spheroids of 250 mm in diameter formed naturally, which we term 
“naturally-formed spheroids”, to determine the maturity of linker-engineered 
aggregates. The target size of 250 mm was chosen for mature naturally-formed 
spheroids as 3D cultures of tumour cells of 200- 250 mm have been reported to 
possess the essential features described above and routinely used for drug 
penetration tests.50 All the results presented in this section were obtained using the 
C3A human hepatic cell line as a model system as C3A cells can aggregate 
naturally, providing a model of natural aggregation process with which to compare 
our engineered aggregation process. 
 
5.2.1 Structural characterisation of linker-engineered aggregates  
Growth kinetics of naturally-formed spheroids and linker-engineered aggregates 
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Naturally-formed spheroids were obtained by seeding single cells into culture 
dishes, placing them on orbital shakers and leaving them to aggregate naturally to 
form spheroids. This rotational culture method of natural spheroid formation was 
chosen to keep the culture condition the same as that used for linker-engineered 
aggregates, to enable fair comparison of the natural with the linker-engineered 
aggregation process. We compared the growth kinetics of naturally-formed 
spheroids and linker-engineered aggregate by measuring the diameters of the 
spheroids or aggregates (Figures 27 and 28). Naturally-formed spheroids took 16 
days to reach the target size of ~ 250 mm in diameter, while linker-engineered 
aggregates took only 7 days. Hence 16-day old naturally-formed spheroids were 
deemed to be mature spheroids, and subsequent characterisation of linker-
engineered aggregates was compared to 16-day old naturally-formed spheroids to 
determine the maturity. 
 
 




Figure 28 Growth kinetics of C3A linker-engineered aggregates. 
Cell morphology 
The cell morphology of linker-engineered aggregates was studied on H & E 
stained cross-sections at different time-points (Figure 29). Representative sections 
of the aggregates / spheroids with the mean diameter for each time point are shown 
in Figures 29 – 32, 34 – 35. Three days after aggregation, the cells have already 
formed a compact 3D structure (Figure 29a). On day 5, cells formed larger 
aggregates with more distinct nuclei staining (Figure 29b). From day 7 onwards 
(Figure 29 (c-f)), the cell morphology closely resembled the mature spheroids 




Figure 29 H & E stained histological cross-sections of C3A linker-engineered 
aggregates (a) – (f) and mature naturally-formed spheroids (g). (a) Day 3, (b) 
Day 5, (c) Day 7, (d) Day 8, (e) Day 9, (f) Day 10 of linker-engineered 
aggregates, (g) Mature naturally-formed spheroids.  Scale bar: 50 mm 
Formation of cell-cell-interaction 
To check for the formation of natural cell-cell interaction other than linker-assisted 
cell-cell interaction, immunostaining for the E-cadherin protein was carried out 
(Figure 30). E-cadherin is an integral membrane protein that forms a part of the 
adherens junction,167 hence an indicator of cell-cell interaction. Three days after 
aggregation, the cells had already expressed E-cadherin abundantly and uniformly 
throughout the whole aggregate (brown membrane-associated extra-cellular 
staining), indicating extensive formation of cell-cell interactions (Figure 30a). A 
similar pattern of E-cadherin staining was seen for linker-engineered aggregates 
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for all the different time points (Figure 30 (b-f)). This uniform expression of E-
cadherin was also observed in the mature 16-day old naturally-formed spheroid 
(Figure 30g), albeit the lighter staining. However, the intensity of the staining is 
highly dependent on individual section and staining process, and may not reflect 
the amount of protein present. Rather, a darker intensity can be due to a slight 
delay in quenching of the peroxidise reaction at the last step of the staining.  To 
better estimate the level of expression of E-cadherin, quantification of the staining 
pattern was carried out using image analysis software ImagePro Plus, whereby 
coloured pixels could be taken into account regardless of their intensity. While this 
method would not give an accurate measure, it provided a semi-quantitative 
estimate of the staining. The level of E-cadherin expression (number of brown 
pixels / number of nuclei in arbitrary units) was expressed as a percentage of the 
level of E-cadherin expression of mature naturally-formed spheroids, and indicated 
at the bottom right corner of each image (Figure 30). Results of the E-cadherin 
quantification showed that from as early as day 3 (Figure 30a), the level of 
expression of E-cadherin (96 ± 20 %) was already similar to that of a mature 
spheroid (Figure 30g, 100 %), suggesting linker-engineered aggregates had formed 
mature cell-cell contacts by 3 days. With time, the amount of E-cadherin increases 




Figure 30 Demonstration of cell-cell interaction: Immunostaining for E-cadherin of 
histological cross-sections of C3A linker-engineered aggregates (a) – (f) and 
mature naturally-formed spheroids (g). (a) Day 3, (b) Day 5, (c) Day 7, (d) 
Day 8, (e) Day 9, (f) Day 10 of linker-engineered aggregates, (g) Mature 
naturally-formed spheroids. (h) negative staining control. Scale bar: 50 mm 
 
Secretion of extra-cellular matrix  
Major components of the hepatic extra-cellular  matrix include fibronectin, laminin, 
collagen type III and collagen type IV.168 To check for the secretion of these 
proteins, immunostaining was carried out on cross-sections of the linker-
engineered aggregates and the mature spheroids. Fibronectin is an extra-cellular 
matrix protein that is involved in the adhesion of cells to the matrix.167 On day 3, 
fibronectin was more concentrated on the periphery of the cellular aggregates 
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(Figure 31a). From day 5 onwards (Figure 31 (b-f)), expression of fibronectin was 
more uniformly expressed throughout the cellular aggregates, similar to the mature 
16-day old naturally-formed spheroids (Figure 31g). As before, quantification of 
the fibronectin staining was carried out and the level of fibronectin expression 
(number of brown pixels / number of nuclei in arbitrary units) is indicated on the 
images. Fibronectin expression levels of linker-engineered aggregates on days 3 
and 5 were low (Figure 31a, b), ~ 50 % of the fibronectin expression level of 
naturally-formed spheroids. On day 7, fibronectin expression increased to ~ 96 % 
(Figure 31c), close to that of natural spheroids (Figure 31g) and remained around 
that level till day 10. This suggested that fibronectin secretion of linker-engineered 
aggregates might have reached a maximum by day 7. 
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Figure 31 Demonstration of ECM secretion: Immunostaining for fibronectin of 
histological cross-sections of C3A linker-engineered aggregates (a) – (f) and 
mature naturally-formed spheroids (g). (a) Day 3, (b) Day 5, (c) Day 7, (d) 
Day 8, (e) Day 9, (f) Day 10 of linker-engineered aggregates, (g) Mature 
naturally-formed spheroids. Scale bar: 50mm 
 
Laminin is another extra-cellular matrix protein that underlies epithelial cells.167 
Likewise, immunostaining for laminin was carried out on cross-sections of cellular 
aggregates and the mature spheroids (Figure 32). On days 3 and 5, laminin was 
more concentrated on the periphery of the cellular aggregates (Figure 32 (a-b)). 
From day 7 onwards, expression of laminin became more uniformly expressed 
throughout the cellular aggregates (Figure 32 (c-f)), resembling the 16-day old 
naturally-formed spheroid (Figure 32g). Results of the laminin quantification 
showed that laminin production was highest during the earlier days, on days 3 and 
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5, where the level of expression of laminin was 125 ± 19 % (Figure 32a) and 122 ± 
2 % (Figure 32b) respectively. By day 7, the amount of laminin dropped to 98 ± 
19 % (Figure 32c), similar to that of a mature spheroid (Figure 32g, 100 ± 13 %), 
and the level of laminin remained consistent around 100 % until day 10. Taking 
into account both distribution and amount of laminin, the day 7 linker-engineered 
aggregate more closely resembled the mature spheroid. 
 
 
Figure 32 Demonstration of ECM secretion: Immunostaining for laminin of histological 
cross-sections of C3A linker-engineered aggregates (a) – (f) and mature 
naturally-formed spheroids (g). (a) Day 3, (b) Day 5, (c) Day 7, (d) Day 8, (e) 
Day 9, (f) Day 10 of linker-engineered aggregates, (g) Mature naturally-
formed spheroids.  Scale bar: 50 mm 
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Collagens are the major proteins of the extra-cellular matrix. Unfortunately, 
immuno-staining for collagen IV proved to be technically challenging. Hence the 
hydroxyproline test was performed to quantitatively determine the total amount of 
collagen present in the linker-engineered aggregates and the mature spheroids 
(Figure 33). Total collagen content of the linker-engineered aggregates was 
normalised to cell number and expressed as a percentage of normalised collagen 
content of the mature naturally-formed spheroids. The collagen content of linker-
engineered aggregates increased gradually from 73.3 ± 9.5 % on day 3 to 107.9 ± 
9.8 % on day 7, where it stabilised around the level of mature spheroids until day 
10. This result suggested that collagen production might have reached a maximum 
in linker-engineered aggregates on day 7. 
 
 
Figure 33 Relative amounts of collagen secreted by C3A linker-engineered aggregates, 
expressed as a percentage of collagen secreted by the mature spheroid (dotted 
line), measured with the hydroxyproline test.  
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Distribution of proliferative cells at the periphery of linker-engineered aggregates 
A key feature of a mature spheroid is the preferential distribution of proliferative 
cells at the spheroid periphery. To study the distribution of proliferative cells, 
bromodeoxyuridine (BrdU) labelling of the linker-engineered aggregates at 
different time-points was carried out (Figure 34 (a-f)) and compared to a mature 
16-day old naturally-formed spheroid (Figure 34g). BrdU binds to DNA in the S-
phase of the cell cycle, hence labelling proliferative cells (black nucleic staining). 
There was no obvious preferential distribution of proliferative cells for aggregates 
of 3 to 5 days old (Figure 34 (a-b)), but the preferential distribution of proliferative 
cells on aggregate periphery became obvious from Day 7 onwards (Figure 34 (c-f)), 
just like in the mature 16-day old natural spheroid (Figure 34g). 
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Figure 34 Distribution of proliferative cells: BrdU labelling of histological cross-
sections of C3A linker-engineered aggregates (a) – (f) and mature naturally-
formed spheroids (g). (a) Day 3, (b) Day 5, (c) Day 7, (d) Day 8, (e) Day 9, 
(f) Day 10 of linker-engineered aggregates, (g) Mature naturally-formed 
spheroids.  Scale bar : 50 mm 
 
Oxygen concentration gradients in linker-engineered aggregates 
To check for the presence of gradients of nutrient concentrations, we investigated 
the oxygen concentration in the spheroids by staining for hypoxia. Hypoxic regions 
are detected with pimonidazole and visualized with immunoperoxidase staining 
(dark regions). Pimonidazole forms adducts with thiol-containing proteins in cells 
with an oxygen concentration less than 10 mm Hg at 37 °C. Hypoxic regions 
(darker regions) in linker-engineered aggregates started appearing on day 7 (Figure 
35c), at ~ 50 mm from the periphery, similar to mature spheroids formed naturally 
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(Figure 35g). After day 7, the hypoxic regions grew larger as the aggregates 
increased in size (Figure 35 (d-f)). This result indicated that linker-engineered 
aggregates of sufficient sizes (Figure 35 (c-f)) experience similar gradients of 
oxygen concentration as mature spheroids (Figure 35g). 
 
 
Figure 35 Gradient of oxygen concentration: Staining for regions of hypoxia on 
histological cross-sections of C3A linker-engineered aggregates (a) – (f) and 
mature naturally-formed spheroids (g). (a) Day 3, (b) Day 5, (c) Day 7, (d) 
Day 8, (e) Day 9, (f) Day 10 of linker-engineered aggregates, (g) Mature 
naturally-formed spheroids.  Scale bar : 50 mm 
 
 
5.2.2 Functional assessment of linker-engineered aggregates  
To further evaluate the maturity of linker-engineered aggregates, three hepatocellular 
functions were monitored at different time points over 10 days and compared to the 
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functional levels of mature 16-day old spheroids formed naturally. All functional 
data were normalised to total cell number estimated using DNA quantification assay. 
 
 Albumin production 
Albumin production of linker-engineered aggregates (Figure 36) on days 3 and 5 
ranged from 0.57 – 0.96 mg per million cells, much lower than that of mature 
spheroids formed naturally (1.44 mg per million cells, dotted line). On days 7, 8 and 
9, albumin production increased to 1.3 – 1.9 mg per million cells, similar to that of 
mature 16-day old spheroids formed naturally. On day 10, albumin production was 
much higher, at 2.7 mg per million cells. Hence linker-engineered aggregates first 
resembled the mature spheroid in albumin production on day 7. 
 
 
Figure 36 Albumin production (normalised to total cell number) of linker-engineered 
aggregates compared to mature spheroids formed naturally (dotted line). 
 
 85 
Cytochrome P450 (CYP450) enzymatic activity 
CYP450 enzymatic activity was measured via 3-cyano-7-hydroxycoumarin (CHC) 
production upon incubation with metabolic substrate 3-cyano-7-ethoxycoumarin 
(CEC). CHC production of linker-engineered aggregates (Figure 37) from day 3 to 
day 9 ranged from 39 – 53 pmol per million cells, comparable to the CHC 
production of mature 16-day old spheroids formed naturally (44 pmol per million 
cells, dotted line). On day 10, however, CHC production dropped to 9.2 pmol per 
million cells, perhaps due to poor accessibility of the CEC to the interior of the 
aggregates, or poor mass transport of CHC to the culture medium as the aggregates 
grew larger. Hence, evaluating from CYP450 activity, linker-engineered 
aggregates first resembled the mature spheroid on day 3. 
 
 
Figure 37 CYP450 activity of C3A linker-engineered aggregates compared to mature 
spheroids formed naturally (dotted line). 
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UDP-glucuronyltransferase (UGT) enzymatic activity 
UGT enzymatic activity was measured via 4-methylumbelliferyl glucuronide (4-
MUG) production upon incubation with metabolic substrate 4-
methylumbelliferone (4-MU). 4-MUG production of linker-engineered aggregates 
from day 3 to day 9 ranged from 1.5 – 2.6 nmol per million cells (Figure 38), 
comparable to the UGT activity of mature 16-day old spheroids formed naturally 
(1.6 nmol per million cells, dotted line), except for day 7 where 4-MUG production 
was significantly higher (2.6 nmol per million cells). On day 10, however, 4-MUG 
production dropped to 1.1 nmol per million cells, possibly due to poor mass 
transport as well. Hence linker-engineered aggregates first resembled the mature 
spheroid in UGT activity as early as day 3. 
 
 
Figure 38 UGT activity of C3A linker-engineered aggregates compared to mature 
spheroids formed naturally (dotted line). 
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Table 1 gives a summary of the results of structural characterisation and functional 
assessment of the linker-engineered aggregates. Considering all the features tested, 
the 7-day old linker-engineered aggregates proved to best resemble mature 
spheroids. Hence as a demonstration for a potential application of linker-
engineered aggregates, 7-day old linker-engineered aggregates were used as 




Table 1  Summary of maturity of C3A linker-engineered aggregates determined via 






When it resembles a mature spheroid 
 
Size (Diameter) Day 7 
Morphology (H & E staining) Day 7 
Cell-cell interaction (E-cadherin) Day 3 
ECM secretion (Fibronectin) Day 7 
ECM secretion (Laminin) Day 7 
ECM secretion (Collagen) Day 7 
Distribution of proliferative cells Day 7 
Development of nutrient gradient 
(Hypoxia) 
Day 7 
Albumin production Day 7 
CYP450 enzymatic activity Day 3 
UGT enzymatic activity Day 3 
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5.2.3 Drug response of mature linker-engineered aggregates 
Drug Penetration 
The mature linker-engineered aggregates (7 days old) were treated with anti-cancer 
drug, doxorubicin, at concentrations of 0.1, 1, 5 and 10 times the peak plasma 
concentration of 0.4 mg ml-1,165 i.e.,at 0.04, 0.4, 2 and 4 mg ml-1, for 24, 48 and 72 
hours. For comparison, 2D monolayer and mature naturally-formed spheroids were 
treated similarly. The penetration of doxorubicin, which is auto-fluorescent, was 
assessed with confocal microscopy (Figures 39 – 41). Doxorubicin kills by 
intercalating proliferating DNA and inhibiting DNA replication,169-171 which 
results in staining the cell nuclei red. Cells were counter stained blue (for live cells) 
and green (for dead cell nuclei). After 24 hours of treatment, doxorubicin showed 
no observable penetration into 2D-cultured cells at 0.04 (data not shown) and 0.4 
mg ml-1 (Figure 39a). Doxorubicin penetration became observable and showed 
dose-dependent penetration into cell nuclei at concentrations ≥ 2 mg ml-1 (Figure 
39 (b-c)). However, despite doxorubicin penetration into the cell nuclei, most of 
the cells were not dead (nuclei were not co-stained green). On the other hand, 
doxorubicin hardly penetrated cell nuclei of linker-engineered aggregates and 
naturally-formed spheroids at 0.4 mg ml-1 (Figure 39 (d, g)), and showed minimal 
penetration at higher concentrations (Figure 39 (e-f), (h-i)). Instead, doxorubicin 
displayed a dose-dependent accumulation at the extra-cellular regions (Figure 39 
(d-i)), a phenomenon not observed in 2D-cultured cells. This illustrated that cells 
cultured in 3D displayed higher resistance to drug penetration than 2D-cultured 
cells, and that linker-engineered aggregates showed similar drug penetration 
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resistance as mature naturally-formed spheroids at the various concentrations 
tested. 
   
 
Figure 39 Penetration of doxorubicin (red) into 2D-cultured C3A cells (a-c) scale bar: 
50 mm, mature C3A linker-engineered aggregates (d-f) and natural spheroids 
(g-i) after 24 hours of doxorubicin treatment at 0.4, 2 and 4 mg ml-1, scale bar: 
20 mm. Cells were counter-stained blue (live) and green (dead). 
 
Similar to previous observations, doxorubicin penetration into 2D-cultured cells 
after 48 hours of treatment at 0.4 mg ml-1 was still not observed (Figure 40a), while 
dose-dependent penetration into cell nuclei at concentrations 2 mg ml-1 and 4 mg 
ml-1 (Figure 40 (b-c)) was observed, with most of the doxorubicin-penetrated cells 
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not detected to be dead (by green nucleic acid dye). Doxorubicin hardly penetrated 
cell nuclei of linker-engineered aggregates and naturally-formed spheroids at 0.4 
mg ml-1 (Figure 40 (d, g)), just like the case after 24 hours of treatment, but showed 
slight penetration at 2 mg ml-1 (Figure 40 (e, h)) and high penetration at 4 mg ml-1 
(Figure 40 (f, i)), starkly different from the case after 24 hours of treatment. 
However, like their 2D counterparts, despite drug penetration into the cell nuclei, 
most of the cells were not dead. 
 
 
Figure 40 Penetration of doxorubicin (red) into 2D-cultured C3A cells (a-c) scale bar: 
50 mm, mature C3A linker-engineered aggregates (d-f) and natural spheroids 
(g-i) after 48 hours of doxorubicin treatment at 0.4, 2 and 4 mg ml-1, scale bar: 
20 mm. Cells were counter-stained blue (live) and green (dead). 
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After 72 hours of doxorubicin treatment at concentrations of 2 and 4 mg ml-1, most 
2D-cultured cells have detached, leaving sparsely distributed cells (Figure 41 (b-c)), 
but doxorubicin penetration into 2D-cultured cells after at 0.4 mg ml-1 was still not 
observed (Figure 41a). Doxorubicin penetration of linker-engineered aggregates 
and naturally-formed spheroids (Figure 41 (d-i)) was similar to those after 48 hours 
of treatment, suggesting that doxorubicin penetration in 3D cultures might have 
reached a maximum after 48 hours of treatment. 
 
 
Figure 41 Penetration of doxorubicin (red) into 2D-cultured C3A cells (a-c) scale bar: 
50 mm, mature C3A linker-engineered aggregates (d-f) and natural spheroids 
(g-i) after 72 hours of doxorubicin treatment at 0.4, 2 and 4 mg ml-1 scale bar: 
20 mm. Cells were counter-stained blue (live) and green (dead). 
 92 
5.3 Engineering 3D cell-dense micro-constructs in a microfluidic system 
In this section, we incorporated the use of the inter-cellular linker into a microfluidic 
system, making use of a micro-fabricated pillar array to control the dimensions of 
the linker-engineered aggregates. This is to ensure reproducibility of the cell-dense 
micro-constructs, as well as to incorporate the linker-engineered constructs into a 
miniaturised and application-ready microfluidics platform. 
 
5.3.1 Design and operation of the microfluidic system 
The 3D microfluidic cell culture system (hereafter referred to as the “3D-mFCCS”) 
was developed to achieve in situ formation and immobilisation of 3D cellular 
aggregates in a microfluidic channel. It consists of a microfluidic channel 1 cm 
(length) ´ 600 mm (width) ´ 100 mm (height) (Figure 42 (a-b)). An array of 
elliptical micropillars, 30 ´ 50 mm, spaced 20 mm apart, is situated in the centre of 
the microfluidic channel. The geometrical design of the micropillar array was 
previously optimised to reduce clogging during cell seeding.132 The micropillar array 
divides the microfluidic channel into a central compartment for cell culture and two-
side compartments for perfusion of culture medium, each 200 mm wide (Figure 
42c). The central cell culture compartment is connected to a cell reservoir inlet for 
cell seeding, and the two-side channels are connected to a perfusion system (Figure 




Figure 42 Design of the 3D microfluidic cell culture system (3D-µFCCS) (a) The 3D-
µFCCS has 2 inlets (1 for culture medium infusion, 1 as cell reservoir) and 1 
outlet. (b) Prototype of the 3D-µFCCS. (c) Dimensions of the 3D-µFCCS. 
Micropillars divided the microfluidic channel into a central cell culture 
compartment and 2 side compartments for perfusion of culture medium. 
 
Before seeding, cells were first treated with sodium periodate to generate aldehyde 
handles on cell surfaces. Modified cells were then suspended in inter-cellular linker 
dissolved in cell culture medium and immediately introduced into the cell reservoir 
to be seeded into the central compartment of the microfluidic channel with a 
withdrawal flow of 0.03 ml h-1 at the outlet. The inter-cellular linker consists of a 
polymeric molecule (polyethyleneimine) with multiple hydrazide arms. During the 
seeding process, the aldehydes on modified cell surfaces reacts with the hydrazides 
on the inter-cellular linker to form a hydrazone covalent linkage, establishing cell–
cell contacts resulting in cell aggregation (Figure 43).  
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Figure 43 Cell seeding into the 3D-µFCCS. Schematic representation of the in situ 
formation and immobilisation of 3D multi-cellular aggregates in the 
microchannel. Cells were suspended in cell culture medium with dissolved 
inter-cellular linker and seeded into the microfluidic channel with a 
withdrawal flow at the outlet. 
 
As the aggregates are withdrawn down the length of the microfluidic channel, they 
snowballed to form larger cell aggregates, which were then confined by the 
micropillar array and accumulated to form a 3D cellular construct (Figure 44a). 
When a fluorescent label was used to visualise the linker, fluorescent rings could be 
seen on cell surfaces (Figure 44b), affirming that the cells were aggregated by the 
linker and supported three-dimensionally by neighbouring cells (Figure 44c).  
 
 
Figure 44 (a) Transmission image of the C3A cellular construct in the 3D-µFCCS after 
seeding. Scale bar: 20 mm. (b) Confocal image of C3A cells aggregated with 
fluorescent inter-cellular linker, showing cells in the construct supported in 
3D by neighbouring cells. Scale bar: 50 mm. (c) Schematic representation of 
the cross-section of the microfluidic channel. Cells are three-dimensionally 
supported by neighbouring cells and confined within the central cell culture 
compartment. 
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To effectively seed the 3D cellular aggregates into the microfluidic channel, 
optimisation of various operational parameters was performed (Table 2) to ensure 
that the in situ formed cellular aggregates were large enough to be confined by the 
micropillar arrays and, yet, small enough to prevent clogging of the microfluidic 
channel. The size of the cellular aggregates can be modulated by the cell density and 
the inter-cellular linker concentration. Different combinations of cell densities and 
linker concentrations were tested, and a cell density of 5–6 million cells ml-1 at inter-
cellular linker concentration of 6–8 mM was found to be optimal for effective 
seeding. At higher cell densities or linker concentrations, massive clogging occurred 
at the inlet; while at lower cell densities and linker concentrations, ineffective 
aggregation of cells saw poor cell entrapment. For all subsequent studies, 6 million 
cells ml-1 at inter-cellular linker concentration of 6 mM was used. The withdrawal 
flow rate during cell seeding was optimised to be 0.02 – 0.05 ml h-1 to ensure high 
cell viability after the seeding process.132  
 
Table 2 Optimised operation parameters for seeding cells into the 3D-µFCCS. 
Parameter Optimal operation window 
Cell density 5 – 6 million ml-1 
Linker concentration 6 – 8 mM 




5.3.2 Perfusion culture of 3D cell-dense micro-constructs 
Perfusion set-up 
To investigate the biological versatility and potential of the 3D-mFCCS as a 
mammalian cell perfusion culture system, we cultured a few model anchorage-
dependent mammalian cells, such as the human lung epithelial cell line A549, 
human liver cell line C3A, and rat primary progenitor cells (BMSCs), using a one-
pass perfusion system (Figure 45). A one-pass perfusion system allows the 
maintenance of a constant cell culture microenvironment over time, without 
accumulation of metabolites or depletion of oxygen and nutrients that is experienced 
by re-circulating perfusion cultures.87 The culture medium was oxygenated by 
passing through oxygen-permeable tubing before entering the bubble trap. Culture 
medium at the end of the perfusion circuit can be collected for assessment of 
metabolic products. The perfusion flow rate for culture of the 3D cellular construct 




Figure 45 Schematic representation of the one-pass perfusion culture system. Culture 
medium was infused into the system by means of a syringe pump, pass the 
bubble trap and valve, into the cell culture chip and can be collected at the 
outlet for analysis of cellular functions. 
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Figure 46 Optimisation of perfusion culture flow rate for maximum cell viability. 
Confocal images of fluorescent viability staining of the C3A cells after 1 day 
of culture with perfusion flow rate (A) 0.01 ml h-1, (B) 0.03 ml h-1, (C) 0.06 
ml h-1, (D) 0.22 ml h-1. Scale bar: 50 mm. (E) Quantification of percentage 
viability of the cells with images from (A) to (D) using software ImagePro 
Plus.  
 
Culture of 3D cell-dense micro-constructs 
When culturing proliferative cell in the 3D-µFCCS, the cellular construct grew 
denser and larger, and could grow beyond the micropillars (Figure 47b). 






onto the floor of the micro channel beyond the micropillar array after 7 days of 
culture (Figure 47b). To check if fluid flow is preventing the cells from spreading 
two-dimensionally, fluid flow was stopped after 1 day of perfusion culture. A day 
after perfusion was stopped, cells in the cellular construct had spread out of the 
central cell culture compartment into the 2 side channels (Figure 48b). This 
suggested that the continuous fluid flow helped to maintain the three-dimensionality 
of the cellular construct. 
 
 
Figure 47 Growth of cellular construct. (a) Cellular construct immediately after seeding 
C3A cells into the microchannel. (b) Cellular construct after 7 days of 




Figure 48 Cells spread out from the central cell culture compartment into the 2 side 
channels after perfusion was stopped. (a) C3A cellular construct after 1 day 
of perfusion culture. (b) C3A cellular construct 1 day after fluid perfusion 
was stopped. Scale bar: 40 mm. 
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Maintenance of viability and 3D morphology of cell-dense micro-constructs 
Three cell types, the human lung epithelial cell line A549, human liver cell line C3A, 
and rat primary progenitor cells (BMSCs) were cultured in the 3D-mFCCS. Cell 
viability after 3 days of perfusion culture was assessed with fluorescence viability 
staining and imaged by confocal microscopy. All three cell types exhibited good cell 
viability (Figure 49a, d, g). Actin visualisation revealed a cortical actin distribution 
typical of the 3D cell morphology for A549 (Figure 49b) and C3A cells (Figure 
49e), in contrast to the stress fibers seen in the 2D-cultured cells (insets). Actin 
labelling of the BMSCs showed less stress fibres within the large aggregates (Figure 
49h) than those present in the 2D cultures (inset). Closer examination of the A549 
and C3A cells using SEM showed rounded cell morphology with gradual merging of 
the cell–cell boundaries indicative of increasing cell–cell interactions over time 
(Figure 49c and f), while BMSCs remodelled into large and tight 3D aggregates with 
smooth surfaces (Figure 49i). These results illustrated that all three cell types 
remained viable and maintained their 3D morphology during the 3-dayperfusion 




Figure 49 Three cell types, C3A, A549 and rat primary BMSCs, in the 3D-µFCCS were 
viable and maintained 3D morphology after 3 days of perfusion culture. (a), 
(d), (g) Confocal images of cells stained with Calcein AM (which stains live 
cells green) and Propidium Iodide (which stains dead cells red) indicated 
good cell viability. Scale bar: 50 µm. (b), (e), (h) Confocal images of F-actin 
staining showed cells with cortical distribution of actin, reminiscent of the 3D 
cell morphology. In contrast, cells in 2D show extensive stress fiber 
formation (insets). Scale bar: 20 mm. (c), (f), (i) SEM images of cells 
illustrated rounded 3D cell morphology with gradual merging of cell–cell 
boundaries. Scale bar: 10 mm. 
 
 101 
5.3.3 Functional assessment of cell-dense micro-constructs  
Functional maintenance of C3A in the 3D microfluidic cell culture system 
To further evaluate the 3D-mFCCS for mammalian cell culture, C3A cells were 
assessed for proliferation and cellular functions over 5 days of perfusion culture. 
Total DNA quantification showed that cell proliferation occurred in the 3D-mFCCS 
during culture (Figure 50a). Synthetic and metabolic functions of C3A cells were 
quantified by measuring the albumin production and UDP-glucuronyltransferase 
(UGT) activity via 4-methylumbelliferyl glucuronide (4-MUG) formation, 
respectively. Albumin production by C3A cells in the 3D-mFCCS ranged from 4.0 to 
5.2 mg albumin per million cells per day over the culture period (Figure 50b), which 
was more than twice the amount (1.8 mg) produced by cells grown in a confluent 2D 
monolayer (dotted line, Figure 50b). C3A cells in the 3D-mFCCS also demonstrated 
higher UGT activity, producing 0.47 – 0.63 pmol 4-MUG per million cells (Figure 
50c), as compared to 0.21 pmol 4-MUG produced by a confluent 2D monolayer 
(dotted line, Figure 50c). The proliferation and maintenance of good cell 
functionality of C3A cells in the 3D-mFCCS throughout the 5-day culture 
demonstrated the reliability of the 3D-mFCCS for culturing and maintaining cellular 




Figure 50 C3A cells cultured in the 3D-µFCCS proliferated and exhibited good cellular 
functions. (a) Total cell number measured showed cell proliferation in the 
3D-µFCCS. (b) – (c) Functional assessment of C3A cells cultured in the 3D-
µFCCS by albumin production (b) and UDP-glucuronyltransferase (UGT) 
activity via 4-methylumbelliferyl glucuronide (4-MUG) production (c) 
showed good cell function compared to cells in a confluent 2D monolayer 
(dotted lines). 
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Osteogenic differentiation of primary rat bone marrow mesenchymal stem cells 
To evaluate the 3D-mFCCS for the culture of sensitive primary cells, we investigated 
the differentiation competence of the BMSCs by differentiating them down the 
osteogenic lineage. BMSCs in the 3D-mFCCS were perfused with osteogenic 
induction medium for 1 week. von Kossa staining for calcium deposits was positive 
for BMSCs aggregates in the 3D-mFCCS (Figure 51a), similar to von Kossa staining 
observed in standard confluent 2D cultures after a 1 week of osteogenic induction 
(Figure 51b). This suggests that the 3D-mFCCS may be useful for the culture and 
study of sensitive primary cells such as the bone marrow-derived adult stem cells.  
 
        
Figure 51 Primary bone marrow mesenchymal stem cells (BMSCs) can be 
differentiated into osteoblasts in the 3D-µFCCS after a 1-week of osteogenic 
induction. (a) von Kossa staining showed calcium salt deposition by BMSC 
in the 3D-µFCCS, similar to the staining obtained in a 2D monolayer control 
(b). Scale bar: 50 mm. 
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5.3.4 Utilisation of the 3D microfluidic cell culture system for drug penetration 
studies 
As a demonstration for a potential application, we performed optical-based drug 
penetration studies with the 3D-mFCCS. C3A cells were seeded and cultured for 7 
days to create a 3D in vitro hepatocellular carcinoma model. The auto-fluorescent 
(red) anti-cancer drug, doxorubicin, was then infused into the 3D-mFCCS together 
with the cell viability dye, calcein AM (green). Live confocal imaging of the 
construct was carried out to visualise drug penetration into the construct (red) and 
loss of cell viability (green) (Figure 52). A quantitative plot of total drug 
penetration and cell viability versus time was obtained from the images (Figure 53). 
Cell viability remained high (95 %) 6 hours after infusing doxorubicin, and started 
to drop noticeably from 9 hours (84 %) when drug penetration picked up. After 19 
hours, cell viability was only 31 % of the initial cell viability. Besides quantitative 
information, spatial information and its variation with time can also be obtained 
from the images (Figure 54) which is useful for studying the penetration of drug as 
a function of time and distance from the site of drug exposure. This demonstrates a 
potential utility of the 3D-mFCCS as a platform for gaining spatial and temporal 






Figure 52 Time-lapse confocal images (2D projection of ~ 60 mm thickness) of the 
cellular construct in the 3D-mFCCS under constant infusion of the 




Figure 53 Quantification of the images in Figure 52, showing total doxorubicin 
penetration (black) into the microfluidic cell construct increasing with time, 
causing a corresponding decrease in total cell viability (green). 
 106 
 
Figure 54 Spatial penetration of doxorubicin into the microfluidic construct as a 
function of time, obtained by analysis of the images in Figure 52. (A) 
Doxorubicin penetration (in arbitrary units) into cellular construct as a 
function of position at different times. (B) Spatial penetration of doxorubicin 







6.1 Evaluation of inter-cellular polymeric linker for engineering a 3D cell-
dense culture model 
6.1.1 Chemistry between inter-cellular linker and cell surface 
To minimise the usage of biomaterials for engineering cell-dense tissues, we have 
mimicked the in vivo developmental process in which cells are first assembled into 
cellular structures for the cells to secrete their own ECM and other environmental 
cues to support themselves. Sialic acids on cell-surface glycoproteins were first 
modified by sodium periodate to generate aldehyde groups. Since aldehydes do not 
react with most functional groups in biological systems,172 the reaction between the 
aldehydes on cell surfaces with the hydrazides on the inter-cellular polymeric 
linker (PEI-hy) to form a hydrazone covalent linkage is highly specific.173 The 
PEI-hy contains multiple hydrazides such that each PEI-hy molecule reacts with 
the aldehyde handles on multiple cells to induce cellular aggregation, as long as 
sufficient PEI-hy linker are in the cell vicinity to interact with the cell-surface 
aldehydes. The positive charges on the PEI backbone promote the electrostatic 
interaction of PEI with negatively-charged proteoglycans present on cell 
surfaces.174-176 The modified cell surfaces, made more negatively charged with 
aldehydes, further facilitate the accumulation of the positively-charged PEI and 
PEI-hy linker molecules near cell surfaces. Modified cells formed small aggregates 
in PEI (Figure 14c), and large aggregates in PEI-hy (Figure 14d) but remained as 
single cells in neutral hydrazide (Figure 14e). While PEI caused slight aggregation 
of cells likely by charge interaction, PEI-hy effectively formed large aggregates by 
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covalently linking aldehyde groups on different cells with its multiple hydrazide 
arms upon accumulation on negatively-charged chemically modified cell surfaces. 
Without the aid of charge interaction, the effective concentration of neutral-
hydrazide on cell surfaces seems insufficient to form aggregates.  
Polyethyleneimine (PEI) was chosen as the polymeric backbone for the 
inter-cellular linker as the amine functional groups can be easily modified under 
aqueous conditions to yield hydrazides (Figure 12). Moreover, since PEI has been 
used as gene transfer vectors, the cytotoxicity of PEI has been studied. Increased 
cytotoxicity has been observed with increase in molecular weight and branching of 
PEI,177 while low molecular weight PEI (MW < 25,000 Da) is known to 
demonstrate low cytotoxicity in cell culture studies.148, 178 In this study, we have 
modified a low molecular weight PEI (MW ~ 1800 Da) into PEI-hy. A 
biocompatibility test of the PEI-hy showed increasing cell viability with decreasing 
PEI-hy concentration (Figure 15), consistent with reports on PEI. A similar test on 
NaIO4 (Figure 16) yielded the same trend. While lower concentrations are more 
biocompatible, cell aggregation efficiency is compromised. Using the 
biocompatible concentration ranges of the NaIO4 and PEI-hy obtained, different 
concentrations of NaIO4 and PEI-hy were tested to select a condition with good 
aggregation efficiency and good initial cell viability to study the cellular behaviour 
of the aggregates during a 7-day culture. The concentration of 0.01 mM PEI-hy 
and 0.50 mM NaIO4 aggregated ~ 75 % of cells with ~ 70 % of the cells remaining 
viable (Figure 19). This condition successfully aggregated a variety of cell types, 
including primary cells like porcine hepatocytes and rat bone marrow stem cells, 
and cell-lines such as HeLa, U251 (Figure 17) and HepG2.  
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Natural cell-cell interaction is mediated by many cell adhesion molecules, 
including the cadherins, the immunoglobulin superfamily, the integrins and the 
selectins,167 of which the cadherins have been found to be particularly important 
for cell-cell adhesion.152 The cadherins are transmembrane glycoproteins which 
mediate Ca2+-dependent homophilic cell-cell adhesion. They play central roles in 
cell-cell recognition and in the structural organization and differentiation of cells. 
Cadherins are the major adhesion receptors of the zonula adherens junctions of 
epithelia, where they associate with actin filament bundles, and the principal 
receptors of desmosomes, where they link to intermediate filament cytoskeletal 
proteins.179   In this work, these natural cell adhesion mechanisms were avoided 
while designing the cell aggregation chemistry so as to minimise intracellular 
signalling responses. Instead, sialic acids, the most common terminal sugar residue 
on cell surface glycoproteins, were chemically modified for inter-cellular linking. 
Chemical modification of the sialic acid has been routinely used for the detection, 
characterization and isolation of glycoconjugates,180 and under mild conditions, it 
has been found to have no significant effects on cell viability and morphology.66, 68 
 
6.1.2 Morphological changes of cellular aggregates during culture 
During a 7-day culture, aggregated HepG2 cells proliferated (Figure 20) while 
maintaining their 3D morphology (Figure 21). ECM was gradually secreted into 
the inter-cellular spaces, blurring cell–cell boundaries (Figure 23) and eventually 
forming a fibrous covering over the entire surface of the aggregates (Figure 23(f)). 
A quantification of the total collagen content showed an overall increase of ~ 75 % 
in collagen secreted by the cellular aggregates after 7 days of culture (Figure 24). 
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Meanwhile, the inter-cellular polymeric linker that initially held the cells together 
gradually disappeared from cell surfaces (Figures 25 and 26). This implies that the 
cellular aggregates are capable of supporting themselves in 3D independently from 
the inter-cellular polymeric linker as the cells proliferate and secrete ECM for 3D 
structural support. The disappearance of the inter-cellular polymeric linker from 
cell surfaces can be due to membrane dilution upon cell division and/or 
endocytosis. Studies on ManLev (a metabolic substrate that is incorporated into 
cell-surface aldehydes) treated cells indicated that the decrease in surface aldehyde 
groups was directly proportional to cell division,65 and hydrazone conjugates were 
endocytosed by cells and subsequently hydrolysed in endosomes.181 Since the 
inter-cellular polymeric linker aggregated cells by forming hydrazone bonds with 
the aldehydes on modified cell surfaces, it is likely that the inter-cellular polymeric 
linker disappeared from the cell surfaces via similar mechanisms. This transient 
residence of the inter-cellular polymeric linker on cell surfaces makes it a good 
candidate biodegradable biomaterial for tissue engineering applications.   
 
6.1.3 Summary for Specific Aim 1 
We have developed a transient inter-cellular polymeric linker (PEI-hy) that can 
rapidly and effectively induce aggregation of live cells, likely through synergistic 
cooperation of the hydrazide arms and the positively-charged backbone of the 
transient inter-cellular polymeric linker with the negatively-charged chemically 
modified cell surfaces. The inter-cellular linker can form viable 3D cellular 
constructs which maintain their 3D integrity independently from the inter-cellular 
linker, likely via establishment of cell-cell interaction and cellular deposition of 
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ECM into the microenvironment. The inter-cellular linker hence provides an 




6.2 Biological characterisation of linker-engineered aggregates  
6.2.1 Aggregate-to-spheroid transformation 
Spheroids are aggregates of cells with compact structures. A mature spheroid 
contains an extensive extra-cellular matrix and possesses a complex three-
dimensional network of cell-matrix and cell-cell interactions.2, 47, 182, 183 For cell 
lines, cells on the periphery of the spheroid are actively cycling, while the 
innermost cells are quiescent and eventually die to form a necrotic core when the 
spheroid enlarges beyond 400 – 600 mm, as a result of the gradients of nutrient 
concentration from the exterior to the centre. 37,49, 50, 183 Some cell types, like those 
of the primary rat hepatocytes, or the A549 human lung cell line, show improved 
cellular functions when cultured as spheroids.27, 154, 184 On the other hand, a cellular 
aggregate is a loose package of cells without these distinct features. It is therefore 
crucial to assess the linker-engineered aggregates for the development of mature 
features during culture in order that linker-engineered aggregates are of 
experimental benefit, either as cancer spheroids for drug testing or 3D cultures for 
tissue engineering purposes. Here we used the C3A cell line as a model to test for 
this aggregate-to-spheroid transformation. As a positive control, we used mature 
C3A spheroids formed naturally under rotational culture. Spheroids of the target 
size of 250 mm in diameter were chosen as the positive control, as various 3D 
cancer models used for drug penetration studies were of the thickness of 200 – 250 
mm.50  
Naturally-formed spheroids reached the diameter of 250 mm after 15 – 17 
days of culture (Figure 27). Hence, 16-day old spheroids were used as the mature 
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spheroid control for all subsequent studies. The cell morphology of linker-
engineered aggregates resembled mature spheroids from 7 days onwards, as 
indicated by H & E - stained sections (Figure 29). Expression of E-cadherin in 
linker-engineered aggregates resembled mature spheroids as early as from day 3, 
both in terms of spatial distribution as well as quantitatively (Figure 30). 
Distribution and amounts of the three ECM proteins, fibronectin, laminin and 
collagen, in linker-engineered aggregates were similar to mature spheroids after 7 
days (Figure 31 - 33). Linker-engineered aggregates at 7 days also displayed 
peripheral distribution of proliferative cells (Figure 34) and experienced similar 
central hypoxia (oxygen concentration below 10 mm Hg) as the mature spheroids 
(Figure 35).  Functionally, linker-engineered aggregates matured at 7 days for 
albumin production (Figure 36) and at as early as 3 days for both CYP450 and 
UGT enzymatic activities (Figure 37 and 38). Taking into consideration all the 
above features, the linker-engineered spheroids were considered structurally and 
functionally mature at 7 days. Hence we have verified that the engineering process 
did not interfere with the maturation process of the 3D cellular aggregates, and that 
the inter-cellular linker can be used to accelerate the formation of mature 3D cell 
cultures. However, it should be noted that the acceleration effect might be cell-type 
dependent. It has been reported that the time taken for a typical tumour spheroid 
with proliferative and viability gradients to form from single cells may take around 
2 to 4 weeks.146 
The formation of a mature spheroid can be divided into 2 parts: The first is 
the “pooling” of many single cells to form a package of cells, which may be a 
result of natural aggregation of cells in a rotational culture and/or the division of 
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single cells to form aggregates in proliferative cells. The second part is remodelling 
of the 3D cellular microenvironment, including the formation of cell-cell 
interactions, secretion of ECM and development of nutrient gradients. The inter-
cellular linker accelerated the formation of spheroids by skipping the first step, that 
is, forcing the aggregation of a large number of cells. For certain cell types that do 
not aggregate naturally,147 the inter-cellular polymeric linker provides a way to 
induce cellular aggregation for applications. Accelerating the formation of 3D 
mature spheroids is beneficial as it would generate savings in terms of time, cost 
and labour. To accelerate the formation of spheroids, various engineering methods 
have been developed. Poly(lactide-co-glycolide) (PLG) and chitosan scaffolds 
have been used to engineer tumour spheroids with superior angiogenic 
characteristics, malignant potential and chemotherapeutic resistance which are 
more in vivo-like than conventional 2D monolayer cultures.28, 185 Alginate 
scaffolds have been used to form C3A spheroids with enhanced liver metabolic 
functions for drug metabolism studies.27 Besides porous matrices, hydrogels have 
also been used to encapsulate cells to form spheroids. Mammary cells were 
encapsulated in Matrigel to form polar structures capable of mammary gland 
specific functions186, 187 while MCF-7 cells were encapsulated in alginate hydrogels 
to form tumour spheroids with high drug resistance.188 More recently, the multicell 
layer model (MCL), which consists of a disc of cells grown from cells seeded on a 
collagen-coated membrane, was developed to mimic the spheroid model but with a 
planar nature to allow easy measurements during drug penetration studies.189, 190 
However, the use of bulk biomaterials like the porous matrices or hydrogels may 
interfere with the formation of a cell-dense tissue structure or even hinder 
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experimental intervention. The use of animal-derived components such as Matrigel 
and collagen with variable properties and pathogenic risks is also not ideal.1, 94 The 
inter-cellular linker hence provides a good alternative method to engineer cell-
dense spheroids for various applications.  
 
6.2.2 Application of linker-engineered aggregates   
Spheroids formed with cell lines form excellent 3D in vitro cancer models for drug 
testing applications. It was found that cancer drug screening methods using 2D cell 
cultures yield little significant correspondence between in vitro or in vivo 
preclinical models and actual clinical results.146, 191 This lack of predictability has 
been attributed to the lack of attention to culture the cells to phenotypically 
represent their in vivo counterparts.50, 73 To better recapitulate the in vivo situation 
in vitro, 3D models like the multi-cellular tumour spheroid (MCTS) model are 
necessary.50  The MCTS model is one of the most studied and established 3D 
cancer models, where cells are held together in 3D by cell-cell interactions and 
features key properties of solid tumours such as cell-cell and cell-matrix 
interactions that are relevant to the penetration of drugs.1, 49, 182 The different cell 
populations present in MCTS are also similar to avascular tumour nodules or 
micro-regions of solid tumours.49, 147,192  Proliferative cells located in the periphery 
of spheroids with direct access to the culture medium are comparable to tumour 
cells situated close to capillaries in vivo that remain active in the cell cycle. The 
quiescent or necrotic cells in the centre of the spheroids which have poor access to 
the culture medium are similar to tumour cells distanced from capillaries in vivo 
that stop cycling and eventually die (Figure 55).49, 146 These features in the MCTS 
 116 
better reflect the in vivo pathophysiological situation in human tumour tissues than 




      
 
Figure 55 Schematic illustrations of the analogy between multi-cellular tumour 
spheroids (MCTS) (A) and inter-vascular tumour regions (B), adapted.47 
 
The inter-cellular linker can be used for rapid formation of MCTS for 
cancer studies.  We have shown that the linker-engineered aggregates remodeled 
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during culture to display the above-mentioned features of MCTS. As a preliminary 
demonstration of the potential application of inter-cellular linker to form MCTS, 7-
day old linker-engineered aggregates, which have been characterised as mature 
spheroids, were used for drug penetration studies. For comparison, mature 
spheroids formed naturally and 2D monolayer cultures were used (Figure 39 - 41). 
Linker-engineered aggregates and mature spheroids displayed similar drug 
penetration resistance at all conditions tested, with dose-dependent extra-cellular 
accumulation of the drug. This observation agrees with reports that tumour cells 
grown as 3D multicellular spheroids rapidly acquire and sustain a drug-resistant 
phenotype in response to drug treatment.193 In contrast, 2D-cultured cells saw 
extensive doxorubicin penetration into cell nuclei, suggesting that the extra-cellular 
matrix present in 3D cultures may be posing a barrier to drug penetration, a 
phenomenon likely to occur in vivo but which cannot be recapitulated using 
conventional 2D cultures in vitro. Since good correlation has been observed 
between resistances to drugs in 3D cultures and tumours in vivo,194, 195 the inter-
cellular linker can be used to accelerate the formation of spheroids as reliable 3D 
in vitro cancer model for cancer studies. Besides accelerating the formation of 
MCTS which would generate savings in terms of time, cost and labour, the inter-
cellular would be particularly useful for cell types that do not aggregate 
spontaneously to form spheroids, e.g. highly metastatic cancer cell lines such as 
AT3, a rat prostate carcinoma cell line, 196 SKOV3, a human ovarian carcinoma 
cell line, or MDA 436, a human breast adenocarcinoma cell line.197  
Cellular aggregates have also been used successfully as building blocks for 
organ printing in hydrogels.198, 199 The inter-cellular linker should achieve the same 
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without the bulk biomaterials such as hydrogels. The 3D cellular support can be 
rapidly established by the inter-cellular linker to form cellular aggregates as the 3D 
basic building blocks, and the desired complex tissue structures can be constructed 
with the help of stenciling methods like dielectrophoretic cell patterning139 or 
microfabrication techniques.200 In the next section, we discuss the use of micro-
fabricated structures to help reproducibly engineer 3D cellular constructs of 
defined dimensions for applications.  
 
6.2.3 Summary for Specific Aim 2 
Linker-engineered aggregates can remodel into mature spheroids upon culture. 
Hence the inter-cellular linker can be used to accelerate the formation of mature 






6.3 Engineering 3D cell-dense micro-constructs in a microfluidic system 
6.3.1 Establishing the 3D microfluidic cell culture system 
The ability to control the dimensions of the cell-dense constructs is important for 
applications as reproducibility is necessary for comparison of data obtained under 
different test conditions, for instance, comparing cellular functions under different 
culture conditions. Hence a combination of inter-cellular linker and micro-fabricated 
structures (a micropillar array) in microfluidic channels was used to create 
reproducible 3D cell-dense micro-constructs, establishing the 3D microfluidic cell 
culture system (termed the “3D-µFCCS”). Cells were suspended in inter-cellular 
linker dissolved in cell culture medium and seeded into the cell culture compartment 
of the microfluidic channel. The inter-cellular linker assisted the formation of 3D 
cellular aggregates in situ as they are withdrawn down the length of the microfluidic 
channel, which are then confined by the micropillar array, resulting in a cellular 
construct of defined dimensions determined by the design of the micropillar array 
(Figure 42). The inter-cellular linker acted as a “cell glue” to stabilise the cellular 
aggregates, such that the cells are supported three-dimensionally by neighbouring 
cells. When proliferative cells were cultured in the 3D-µFCCS, the cellular construct 
grew while maintaining their 3D morphology (Figure 47). 
At the same time, we created a novel method for seeding and culturing 
mammalian cells three-dimensionally in microfluidic systems relieved of hydrogels 
for 3D extra-cellular support, which has various advantages. Compared to 
microfluidic systems that utilise hydrogels for 3D cell encapsulation,131, 141, 156 the 
use of inter-cellular linker to effect 3D cell culture in the gel-free 3D-µFCCS 
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facilitates the establishment of a more natural extra-cellular matrix (ECM) 
environment. This is because the polymeric inter-cellular linker is transient (i.e. 
gradually disappears from the cell surfaces with a half-life of ~ 2 days) (Figure 26),  
thus allowing cells to secrete and remodel their own ECM environment for 
maintaining 3D structural integrity and morphology.38 The presence of an ECM 
environment endogenous to a specific cell type in the gel-free 3D-µFCCS may 
promote more in vivo-like cellular phenotypes when compared to microfluidic 
systems incorporating exogenous ECM hydrogels since cellular phenotypes are 
highly dependent on the chemical and mechanical properties of the ECM.1  
From an operational point of view, seeding and forming a 3D cell construct 
in the 3D-µFCCS is simple. Cells are chemically modified, suspended with the inter-
cellular linker, and introduced into the microfluidic channel; after the central cell 
compartment of the channel is filled with cells, the cell reservoir is closed and 
culture medium is perfused, completing the cell seeding process. Where hydrogels 
are used to provide 3D cellular support in other microfluidic systems, additional 
steps are required to induce in situ matrix gelation within the microfluidic channel 
either by photopolymerisation,201 self-assembly of oligopeptides,141 hydrodynamic 
focusing,141 or polyelectrolyte complex coacervation.132, 142  These steps are more 
time-consuming and/or require the use of additional fluidic components, such as 
valves, pumps and connectors to control the delivery of different reagents. In some 
hydrogel-based systems, suspension of cells in hydrogels is loaded into open 
microfluidic channels while sealing of the channel is carried out only after the 
hydrogel has solidified.156 Such operational complexity increases the likelihood of 
contamination and failure, and poses additional challenges for multiplexing design 
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and operation which can be alleviated by using the inter-cellular linker in place of 
the hydrogels for 3D cellular support. 
 
6.3.2 Application of the 3D microfluidic cell culture system 
We demonstrated the utility of the 3D-µFCCS by successfully culturing and 
maintaining the 3D phenotypes of model anchorage-dependent mammalian cells, 
which included carcinoma cell lines (A549 and C3A) and primary bone marrow 
mesenchymal stem cells (BMSC) (Figure 49). These cell types represent biologically 
relevant 3D in vitro models that can be established with the 3D-µFCCS for 
biological research and drug screening applications. For instance, A549 human lung 
epithelial cells cultured as 3D cellular aggregates were shown to express increased 
epithelial cell-specific markers compared to their 2D monolayer counterparts, thus 
providing a more physiologically relevant model for studying lung infections.184 
C3A human hepatocytes cultured as 3D spheroids exhibited enhanced drug 
metabolism activities compared to the cells cultured in 2D monolayer, hence 
providing an efficient experimental tool for predicting drug responses in vivo.27 The 
3D-µFCCS is also capable of supporting sensitive primary mammalian cells, such as 
mesenchymal stem cells (Figure 49, Figure 51). Stem cells are highly prized in 
regenerative medicine for their ability to self-renew and differentiate into multiple 
lineages. Its differentiation fate is influenced by specialised microenvironments or 
cell niche that remain poorly defined.202, 203 In addition, 3D perfusion culture of 
BMSCs has been demonstrated to provide a more physiological environment than 
conventional 2D cultures for studying proliferation and differentiation.4  
Microfluidic platforms such as the 3D-µFCCS offer the potential for manipulating 
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the cell niche by allowing different microenvironmental factors to be tested 
simultaneously when integrated with gradient generators, and maintaining a constant 
cell microenvironment with one-pass perfusion.9, 87  
Carcinoma cell lines can be cultured in the 3D-µFCCS to engineer 3D in 
vitro cancer models, in particular, the multi-cellular tumour spheroid (MCTS) 
model, for drug testing applications (Figure 52). The incorporation of 3D cell culture 
into microfluidic systems has been envisioned to benefit drug screening efforts as 
increasing evidence showed that cancer cells cultured in 3D resemble tumours in 
vivo more closely than cells cultured in 2D.146, 204 Moreover, the microfluidic 
environment closely imitates the in vivo situation (Figure 56),188 with the fluidic 
introduction of drugs more closely approximating the dose dynamics experienced in 
vivo, compared to static incubation of cells with a bolus dose of drugs.75 The 
dimension of the microfluidic cell construct can also be varied with microfabrication 
design to lie within a range of 150 – 250 mm that is relevant for drug penetration 
studies,50, 189, 205 or to any in vivo situations. While there exists a few microfluidic 
systems that can support carcinoma cell lines in 3D, they are unable to recapitulate 
the multi-cellular tumour spheroid (MCTS) model as the cells are encapsulated in 
hydrogels.132, 141, 156 In comparison, the 3D-µFCCS is able to form MCTS-like cell-





Figure 56 The microfluidic environment closely imitates the in vivo tumour 
microenvironment. (a) A schematic showing the in vivo tumour 
microenvironment with vasculature (red), adapted.188 (b) The 3D-µFCCS 
with a perfusion of culture medium or drugs (red arrows) resembling the in 
vivo situation. 
 
The transparent microfluidic platform allows is also compatible with optical-based in 
situ assays that utilise fluorescence reporters and high resolution imaging modalities, 
such as confocal microscopy,119 to probe cellular events or monitor cellular 
responses, enabling drug penetration studies to be carried out with good spatial and 
temporal resolution (Figure 52). The 3D-µFCCS  is also amenable to multiplexing 
for high throughput analyses114, 206, 207 and integrating microfluidic components such 
as concentration gradient generators100, 115 and computer-controlled on-chip valves, 
pumps and analytical systems.74, 116 These would allow real-time monitoring of 
cellular events while simultaneously testing the effects of different drug 
concentration or flow rates on drug penetration efficiency. The biological versatility 
and simple operation of the 3D-µFCCS makes it a suitable platform to be further 
adapted for biological research and drug screening applications, enabling the 
acquisition of in vitro data that is more predictive of in vivo responses in a high 
content and high throughput approach.  
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6.3.3 Summary for Specific Aim 3 
With the help of micro-fabricated structures, the inter-cellular linker can form 3D 
cell-dense micro-constructs of reproducible dimensions for applications. At the 
same time, the inter-cellular linker offers a novel gel-free method for seeding and 
culturing mammalian cells three-dimensionally and at high packing density in 







6.4 Inter-cellular polymeric linker as a novel biomaterial for engineering 3D 
cell-dense constructs 
We have developed a novel biomaterial, the inter-cellular polymeric linker, for 
engineering 3D cell-dense constructs. By forming cellular aggregates with the 
inter-cellular polymeric linker, anchorage-dependent cells can be supported by 
neighbouring cells three dimensionally, eliminating the need for bulk scaffolds like 
porous matrices or hydrogels, hence creating a cell-dense construct. The inter-
cellular linker also potentially allows formation of complex 3D tissue architecture 
not confined to sheets or spheroids when used in combination with other 
technologies like dielectrophoretic patterning to control the 3D spatial arrangement 
of cells. The inter-cellular linker has minimal cytotoxicity and resides only 
transiently on cell surfaces; hence it does not interfere with but in fact accelerates 
the growth and maturation of the cellular constructs during culture. The inter-
cellular linker is also versatile to be used in miniaturised cell culture systems like 







7. CONCLUSION  
This thesis has documented the development of a transient inter-cellular polymeric 
linker (PEI-hy) that can rapidly and effectively induce aggregation of live cells to 
effect cell-dense 3D culture using minimal biomaterials. The cells in the cellular 
aggregates can proliferate and preserve the 3D structural integrity independently 
from the inter-cellular linker. Structural characterisation and functional assessment 
showed that the cellular aggregates remodelled during culture to exhibit features of 
a mature 3D spheroid with formation of adherens junctions, secretion of extra-
cellular matrix, development of gradients of cell proliferation and oxygen 
concentration from the periphery to the centre, good cellular functions and drug 
resistance. Cellular aggregates also displayed drug penetration resistance like 
mature spheroids. We further incorporated the use of the inter-cellular linker into a 
microfluidics system to take advantage of the micro-fabricated structures and 
fluidic properties for reproducibility of cellular construct and culture 
microenvironment which are crucial for applications. At the same time, the inter-
cellular linker offers a novel gel-free method for seeding and culturing mammalian 
cells three-dimensionally in microfluidic systems, exhibiting numerous advantages 
over hydrogel-based systems. The linker-engineered cellular constructs cultured in 
the microfluidic system showed good cell viability, preserved the 3D cell 
morphology, and exhibited good cell functionality and differentiation capability. 
The microfluidic cell culture system was also showed to be a useful platform for 
optical-based studies with good spatial and temporal resolution. 
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8. RECOMMENDATIONS FOR FUTURE RESEARCH  
Using inter-cellular linker to facilitate heterotypic cell-cell interaction  
In this work, the inter-cellular linker was used only for aggregating homotypic 
cells. Facilitating heterotypic cell-cell interaction in vitro to mimic tissue structures 
in vivo would be the next step towards engineering functional tissues. For instance, 
the islets of Langerhans in the pancreas have a distinct architecture whereby non-
beta cells surrounds a mass of beta cells in the centre.208 These homotypic and 
heterotypic cell-cell interactions are necessary for responding to different nutrient 
stimuli.209, 210 In engineering tumour models, tumour cells can be co-cultured with 
other cell types to study interactions between the tumour cells and other cells. For 
example, tumour cells can be cultured with immune cells to study infiltration of 
immune cells into tumours;211 or with endothelial cells to study angiogenesis;212 or 
with fibroblasts to study tumour cell invasion.213 The inter-cellular linker can be 
used to facilitate these heterotypic cell-cell interactions in vitro to mimic the in 
vivo situations. 
 
Inter-cellular linker with different functional groups 
In this work, sialic acid residues on cell surface glycoprotein were chemically 
modified with sodium periodiate to yield aldehyde functional groups, which served 
as molecular handles for the hydrazides on the inter-cellular linker to react with. 
This two-step process can be further reduced into one, if functional groups that 
react with cell surface receptors can be conjugated onto the inter-cellular linker. 
For instance, galactose groups can be conjugated onto PEI to form PEI-galactose 
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inter-cellular linker, which can be used to aggregate hepatoma cells which display 
the asialoglycoprotein receptor (ASGPR) for galactose ligands on cell surfaces.214 
 
Three-dimensional patterning of cells  
This method to form 3D cell-dense cultures with inter-cellular linker does not exert 
spatial control of the cells to form constructs of desired shapes and structures. One 
way to do that is to use external physical forces to organise the cells into a 
structure, and then “lock” the cells in the specific organisation with inter-cellular 
linker. Dielectrophoretic forces for cell manipulation has been used to fabricate 
tissues of varying microstructures.139, 215, 216  Another technique which uses 
computer-aided jet-based patterning of cells to form cellular structures, also known 
as “organ printing”,37, 198 can also be of use. Both techniques are carried out with 
cell suspension in liquid hydrogels, which are subsequently solidified to lock the 
cells in place after patterning. With inter-cellular linker, patterning and cell culture 
would not be confined to take place within hydrogels, which potentially opens up 
more avenues for innovation. 
 
Studying gene expression of linker-engineered aggregates 
It has been widely reported that cells cultured in 3D in vitro exhibited phenotypes 
that are different from those in conventional 2D monolayer cultures, and may 
mirror their in vivo counterpart more closely.2, 146, 217 These claims were validated 
by assessing the three-dimensionally cultured cells for their gene expression 
profiles,15 their expression of various differentiated markers (e.g., albumin 
production in hepatocytes or alkaline phosphatase activity in osteoblasts),14, 218, 219 
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as well as the spatial localisation of structural proteins like F-actin, E-cadherin, and 
vinculin.16, 220 In this thesis project, we have developed an inter-cellular polymeric 
linker that enables the development of 3D in vitro cell-dense culture models in 
both the macro-scale / static (e.g. petri dishes) and the micron-scale / dynamic (e.g. 
microfluidic systems) environments. It is therefore of interest to investigate the 
differences in gene expression profiles between cells cultured in 2D and 3D, and 
between cells cultured in static and dynamic 3D environments. The gene 
expression profiles of cells cultured in the in vitro model can also be compared to 
that of cells in vivo, to determine how closely the 3D in vitro model mimics the in 
vivo situation. 
 
Utilisation of the 3D microfluidic cell culture system for high content screening 
The transparent nature microfluidic cell culture system can be further exploited to 
monitor various dynamic cellular events in live cells simultaneously, in other 
words, for high content screening.221 The constant cell culture microenvironment 
provided by perfusion is also useful for minimising cellular responses to 
environment changes when performing live-cell experiments. High content 
screening has revealed valuable functional information by taking into account the 
intracellular localisation, transport and temporal and spatial control of the activity 
of biomolecules including DNA, RNA and proteins.222, 223 This allows us the 
ability to discern inter-relationships of processes affecting cellular organelles.224 
For instance, during the introduction of drugs to the microfluidic cellular construct, 
besides monitoring for cell viability, we can simultaneously monitor other 
apoptosis markers like mitochondrial membrane potential (MMP), nuclear 
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morphology, membrane permeability; or cellular oxidative stress markers like 
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APPENDIX A IMAGE ANALYSIS  
 
 
Figure 57 Segmentation of images (a) into nuclei staining (b) and protein staining (c) 
with image analysis software, ImagePro Plus.  
To quantify the histological staining, the digital images were segmented into blue 
(counter-staining of nuclei with hematoxylin) and brown pixels (protein of interest). 
The area selected to be quantified was highlighted in grey (images on the right), 
and numbered or outlined in green by the software. The number of brown pixels 
and number of blue objects (nuclei) were then quantified. The level of protein 
expression was expressed as number of brown pixels divided by number of nuclei, 
in arbitrary units. 
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APPENDIX B REVERSIBLE SEALING OF MICROFLUIDIC 
CHANNEL 
` 
Figure 58 (a) Clamps used for reversible sealing of the microfluidic channel for SEM 
processing of the microfluidic cellular construct. The clamps were custom-
made with polycarbonate, designed with 3 holes for tubing and cell reservoir 
(top piece (b)), and a window in the centre for viewing under an inverted 
microscope (bottom piece (c)). A polyethylene (PE) film was placed between 
the PDMS channel and a cover slip. The whole set-up (PDMS + PE film + 
cover slip) was then clamped and tightened with the screws. After 3 days of 
culture, the cellular construct was fixed and the clamps removed. The cover 
slip was removed and the PE film peeled off carefully to expose the cellular 
construct for SEM processing. 
 
 
